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In budding yeast, the phosphatase Cdc14 is released from nucleolus to promote
mitotic exit (ME). Cdc14 release and ME is controlled by mitotic cyclin-Cdk
oscillation, the FEAR network including a non-proteolytic function of separase (Esp1),
and the Mitotic Exit Network (MEN) indirectly activated by spindle elongation
through cohesin cleavage by the proteolytic function of Esp1.

The MEN contributes strongly to ME efficiency.

Esp1 contributes to Cdc14

release and ME kinetics mainly through cohesin cleavage: the Esp1 requirement can
be largely bypassed if cells are provided Esp1-independent means of separating sister
chromatids. In the absence of Esp1 activity we observed only a minor ME delay
consistent with a FEAR defect. Esp1 overexpression drives ME in Cdc20-depleted
cells arrested in metaphase. We have found that this activity of overexpressed Esp1
depended on spindle integrity and the MEN.

Quantitative measure of Cdc14

localization indicates efficient Cdc14 release upon MEN activation; release driven by
Esp1 in the absence of microtubules was inefficient and incapable of driving ME.

Reducing mitotic cyclin-Cdk activity is critical for ME, but Cdc14 release and
resequestration is not blocked by endogenous undegradable mitotic cyclin Clb2.
Using quantitative time-lapse microscopy, we demonstrate an intrinsic oscillatory
module controlling Cdc14 localization.

This autonomous Cdc14 release oscillator

functions at constant cyclin-Cdk levels by titrated introduction of undegradable Clb2,
and at cell-cycle-average Clb2 levels given a block of cell cycle progression by actin
depolymerization.

Using genetic manipulations, we demonstrate that this oscillator

can operate in free-running cell cycles even without undegradable Clb2. The
Cdc14-Cdh1-Cdc5 negative feedback is the primary mechanism driving this release
oscillator. Its mechanism and regulation of its frequency by Clb2-Cdk, suggest the
hypothesis that intrinsically autonomous Cdc14 release cycles are locked at once per
cell cycle through entrainment by the cyclin-Cdk oscillator. This concept
incorporates autonomous cell cycle oscillators previously reported into a coherent cell
cycle control by cyclin-Cdk oscillation, therefore, may have broad implications for
the structure and evolution of eukaryotic cell cycle.
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Chapter 1: Introduction

Mitotic exit (ME) is a transitional stage connecting mitosis to the start of the next
cell cycle. In budding yeast Saccharomyces cerevisiae, ME refers to a collection of
events happening within ~15 minutes from anaphase until rebudding, including
spindle disintegration, cytokinesis, mitotic cyclin inactivation, and DNA replication
origin licensing.

It is important that those events should only happen during ME,

and in the right sequence for a normal cell cycle progression. Molecular
mechanisms regulating ME involve phosphorylation/dephosphorylation, protein
proteolysis, protein localization change, protein complex formation, and gene
transcription.

A key issue is to understand what commits the cell to exit from

mitosis, and how various ME events are controlled efficiently and accurately.

Cyclins and cyclin dependent kinase (Cdk) are at the center of the eukaryotic cell
cycle control system (Morgan, 2007).

Mitotic cyclin-Cdk activity rises and falls

once per cell cycle in all eukaryotes. In budding yeast S. cerevisiae, mitotic cyclins
(Clb1,2,3,4) are required for mitotic entry (spindle assemble and anaphase), however
overexpression of mitotic cyclins prevents ME, resulting in telophase arrest (Surana et
al., 1993). If mitotic entry requires high mitotic cyclin-Cdk activity, and ME
requires low Cdk activity (King et al., 1994; Murray and Kirschner, 1989), then the
oscillation of mitotic cyclin-Cdk activity would render ME dependent on previous
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mitotic entry, resulting a ‘ratchet’-like control of mitosis. Ratchet-like control of this
nature is most prominently documented in the case of DNA replication, where high
cyclin-Cdk simultaneously blocks DNA replication origin reloading, and promotes
firing of previously loaded origins; this control yields once-per-cell-cycle replication
(Kearsey and Cotterill, 2003).

These ideas have been generalized to spindle

morphogenesis, function and disassembly, and to mitotic control overall, although the
evidence for these other systems is less complete.

In S. cerevisiae, the oscillation of mitotic cyclin-Cdk activity is primarily a
product of periodic transcription and proteolysis.

The anaphase promoting complex

(APC), bound to its activator Cdc20 and Cdh1, mediates Clb proteolysis (Visintin et
al., 1997; Yeong et al., 2000).

Full activation of APC-Cdc20 complex at the

metaphase-to-anaphase transition requires phosphorylation of APC subunits by
mitotic cyclin-Cdk (Cross, 2003). Active APC-Cdc20 mediates proteolysis of
securin Pds1, resulting in activation of separase Esp1 (Cohen-Fix et al., 1996).
can cleave cohesin subunit Scc1 to promote anaphase (Uhlmann et al., 2000).

Esp1
In S.

cerevisiae, APC-Cdc20 partially degrades mitotic cyclins (Clb1,2) (Yeong et al.,
2000).

Further down-regulation of mitotic cyclin-Cdk activity requires APC-Cdh1

and the stoichiometric inhibitor Sic1 (Mendenhall and Hodge, 1998).
Phosphorylation of Cdh1 by Cdk prevents its interaction with APC and nuclear
accumulation (Shirayama et al., 1998).

Cdh1 is dephosphorylated by the

phosphatase Cdc14 during ME, and results in complete degradation of mitotic cyclins
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(Jaspersen et al., 1999). Sic1 can inhibit Clb-Cdk activity independent of
proteolysis .

Both transcription and stability of Sic1 is cell cycle regulated (Verma

et al., 1997).

Sic1 transcription in mitosis is activated primarily by Swi5, which is

activated by Cdc14 through dephosphorylation (Toyn et al., 1997; Visintin et al.,
1998).

Cdc14 also dephosphorylates Sic1 to prevent its proteolysis (Visintin et al.,

1998).

Cdc14 is a major phosphatase and a key regulator during ME, and is highly
conserved among eukaryotic species.

In budding yeast, Cdc14 is essential for cell

viability. The activity of Cdc14 is mainly regulated through changing its localization.
Cdc14 is sequestered in the nucleolus by the RENT complex (including Net1) during
G1, S and G2; this probably sequesters it from most targets, and additionally, Net1
may inhibit Cdc14 enzymatic activity; therefore, Cdc14 is likely inactive through this
time (Shou et al., 1999; Visintin et al., 1999). Cdc14 is released from Net1 and the
nucleolus into the cytoplasm only during ME (Net1 is constitutively nucleolar).
Three major pathways release Cdc14 from nucleolus, including the FEAR network
(cdc Fourteen Early Anaphase Release) which is activated by a non-proteolytic
function of separase Esp1 at early mitosis to promote a transient release of Cdc14; the
MEN (Mitotic Exit Network) which is activated through the Tem1-Cdc15-Dbf2 signal
transduction cascade to promote Cdc14 release in later mitosis; in addition, the polo
kinase Cdc5 is essential for Cdc14 release, and is required for full activation of FEAR
and MEN pathways (Bardin et al., 2000; Stegmeier and Amon, 2004; Stegmeier et al.,
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2002; Visintin et al., 2003).

Cdc5 can also promote Cdc14 release by

phosphorylating Cdc14 and the RENT complex to promote their disassociation
(Visintin et al., 2003).

The FEAR network is activated by the non-proteolytic function of Esp1 in early
mitosis (Sullivan and Uhlmann, 2003).

Esp1 can interact with Cdc55 (PP2A

co-factor) to cause Net1 phosphorylation by mitotic cyclin-Cdk to promote a transient
release of Cdc14 (Queralt et al., 2006).

Besides Esp1, Slk19 and Spo12 are also

essential components for the FEAR network (Stegmeier et al., 2002).

The MEN network (also called spindle orientation checkpoint, SPOC) is activated
in response to anaphase which pushes the daughter-orientated spindle pole body (SPB)
into the bud (Bardin et al., 2000). Then the MEN component Tem1 which localizes at
SPB gets close to the bud cortex where Tem1’s guanine exchange factor Lte1 sits.
This movement of SPB could lead to the activation of Tem1, and leads to a serial
activation of Cdc15 and Dbf2/Mob1 complex.
promote its disassociation with Cdc14.

Dbf2 can phosphorylate Net1 to

BUB2 is essential for SPOC regulation of the

MEN; in bub2Δ cells, the MEN network is likely near-constitutively active (Fesquet
et al., 1999; Pereira et al., 2000).

Cdc14 released by the MEN network induces mitotic cyclin-Cdk inactivation, and
directly promotes cytokinesis (Stegmeier and Amon, 2004). Cdc14 released by the
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FEAR network can facilitate rDNA segregation, spindle elongation, and nuclear
positioning (D'Amours et al., 2004; Higuchi and Uhlmann, 2005; Ross and Cohen-Fix,
2004; Sullivan et al., 2004; Wang et al., 2004).

It has also been proposed that the

MEN component Cdc15 need to be dephosphorylated by FEAR-released Cdc14 for
full activation of the MEN network (Jaspersen and Morgan, 2000; Stegmeier et al.,
2002).

Cdc14 initially released by the FEAR network may promote MEN activity to

induce additional Cdc14 release, and therefore, forms a positive feedback loop to
cause rapid release of Cdc14 from nucleolus (Sullivan and Uhlmann, 2003).

The

non-proteolytic function of Esp1 has been suggested to be essential for ME (Sullivan
and Uhlmann, 2003), although the FEAR network components Slk19 and Spo12 are
dispensable for the cell cycle.

In slk19 Δ and spo12Δ cells, ME is delayed by 10~15

minutes (Stegmeier et al., 2002).

Preventing Net1 phosphorylation by mitotic

cyclin-Cdk, proposed to be a key FEAR pathway event, also only delays ME by 10-15
min (Azzam et al., 2004).
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Figure 1.1. Major proteins and their interactions in mitotic exit control system.
Arrow heads stand for activating interactions; blunt heads stand for inhibitory
interactions.

Abbreviations: P, phosphorylation; DP, dephosphorylation; U,

ubiquitination; X, protein cleavage; [GAL], requiring overexpression from GAL1
promoter; B, binding; G.Ex, guanine exchange reaction. Green symbols: proteins in
the FEAR network; Red symbols: proteins in the MEN network; Blue symbols:
proteins involved in regulating cyclin-Cdk activity. Those classifications are not
exclusive. The ‘+’ symbol in green stands for logic AND.
modules in mitotic exit and their general interactions.

6

The inset panel shows

The networks controlling Cdc14 release and ME are highly interdigitated (Fig.
1.1).

Therefore, although many possible interactions have been reported, it is

difficult to envisage the dynamical behavior of the system, and a comprehensible
model is often complicated by less important interactions due to the lack of its
dynamical information.

For example, the FEAR and the MEN networks can be

activated in many different ways; it is still unclear how those pathways are activated
in a normal cell cycle, because the experimental conditions to establish those
interactions are generally different.

Especially, it is unclear about the role of

cyclin-Cdk activity in controlling those pathways.

Most proteins involved in the

system are potentially Cdk substrates with both positive and negative interactions. It
is also unclear whether Cdc14 release alone is sufficient to induce ME, since separase
Esp1 and several MEN components have been reported to be directly involved in
controlling ME events (Jensen et al., 2001; Jimenez et al., 2005; Tinker-Kulberg and
Morgan, 1999).

This thesis is divided into two parts.

The first part addresses the question of

which signal ultimately leads to ME, and the relative importance of various pathways
in this process.

The second part tries addresses the question of how Cdc14 release

and resequestration is controlled by mitotic cyclin-Cdk activities.

7

Chapter 2: Materials and Methods

Strains and plasmids
All strains are in the W303 background. Their genotypes are shown in Table 2.1.
Strain constructions were carried out by standard tetrad analysis and transformation
methods.

We used strains containing a CDC14 allele endogenously tagged with YFP,

in order to follow Cdc14 trafficking.

This CDC14-YFP was previously shown to

fully complement, and to be competent for FEAR- and MEN-induced nucleolar exit
(Pereira et al., 2002).

GAL1-CLB2kd-GFP was constructed by C-terminally tagging

GAL1-CLB2kd construct with GFP, and integrated at URA3 locus. NET1-mCherry
was constructed by C-terminally tagging the endogenous NET1 with mCherry.
CDC5pr-GFP-PEST was first constructed on a plasmid, and inserted at the
endogenous CDC5 locus.

The pYL8 plasmid (pRS303-GALS-esp1frag.. esp1frag, created by truncating a
2.6kb region from the ESP1 ORF using SphI) was linearized with BlpI and integrated
into the genome to make esp1::GALS-ESP1. ESP1::GALS-ESP1 was made alike, but
using plasmid pYL10 which had a full length ESP1 ORF under the GALS promoter.
Correct number of integration was confirmed by real time PCR. The construction of
PDS1-mdb esp1::GALS-EPS (or ESP1::GALS-ESP1) strains was the following: A
pds1::LEU2 strain was first transformed with pYL7 (pRS406-PDS1-mdb, linearized
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with MluI), then the URA3 marker in the resulting strain was counter-selected on
G+FOA plates to obtain Leu- Ura- clones. The structure of the pop-out strain was
confirmed by PCR and Southern blot.
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Table 2.1. Strains and Genotypes.

All strains are W303 background. Strains

construction is using standard methods.
Strain name

Genotype

2151-7B

bar1 w303

YL0931

cdc20::MET-CDC20-TRP1 ura3::GAL-SIC1-4A-URA3

YL1721

cdc20::MET-CDC20-TRP1 ura3::GAL-SIC1-4A-URA3

2147-3D

cdc20::LEU2 ade2::GALL-CDC20-ADE2 pds1::URA3

YL094

cdc20::MET-CDC20-TRP1 esp1-2td-URA3 GAL-UBR1-HIS3 ura3::GAL-SIC1-4A-URA3 leu2::ESP1C1531A-LEU2

YL122

cdc20::MET-CDC20-TRP1 GFP-TUB1-HIS3 MYO1-GFP-KAN ESP1::GALS-ESP1C1531A-URA3

YL353

cdc20::MET-CDC20-TRP1 scc1::HIS3 SCC1-TEV-LEU2 GAL-TEV-TRP1 GAL-SIC1-4A-URA3

353

cdc20::MET-CDC20-TRP1 scc1::HIS3 SCC1-TEV-LEU2 GAL-TEV-TRP1

BD96B-4C

cdc20::MET-CDC20-TRP1 GFP-TUB1-HIS3 MYO1-GFP-KAN

YL113

pds1::PDS1-mdb ESP1::GALS-ESP1-TRP1 trp1::LacO-LEU2,TRP1 his3::LacR-GFP-HIS3 MYO1-GFP-KAN

YL115

pds1::PDS1-mdb esp1::GALS-ESP1-TRP1 trp1::LacO-LEU2,TRP1 his3::LacR-GFP-HIS3 MYO1-GFP-KAN

YL018

pds1::PDS1-mdb ESP1::GALS-ESP1-TRP1

YL114

bar1 pds1::PDS1-mdb esp1::GALS-ESP1-TRP1

YL139

bar1 pds1::PDS1-mdb-18MYC ESP1::GALS-ESP1-TRP1

YL049

bar1 mad2::KAN scc1::HIS3 SCC1-TEV::LEU2 GAL-TEV-TRP1

YL057

bar1 mad2::KAN scc1::HIS3 SCC1-TEV::LEU2 GAL-TEV-TRP1 GAL-PDS1-mdb-URA3

YL044

bar1 mad2::KAN scc1-73 leu2::GAL-PDS1-mdb-LEU2

YL0451

bar1 mad2::KAN leu2::GAL-PDS1-mdb-LEU2

YL1361

cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 CDC14-YFP-HIS3 NET1-CFP-KAN MYO1-GFP-KAN

YL1362

cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 cdc15-2 CDC14-YFP-HIS3 NET1-CFP-KAN

YL121

cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3

YL1451

cdc20::MET-CDC20-TRP1 trp1::6xGAL-ESP1 CDC14-YFP-HIS3 NET1-CFP-KAN

YL1452

cdc20::MET-CDC20-TRP1 CDC14-YFP-HIS3 NET1-CFP-KAN

ALG611

bar1 clb2::CLB2,kd trp1::2xGAL-SIC1-TRP1 CDC14-YFP-HIS3 NET1-CFP-KAN MYO1-mCherry-HIS3

YL165

cdc20::MET-CDC20-TRP1 cdh1::LEU2 ESP1::GALS-ESP1-URA3 CDC14-YFP-HIS3 NET-CFP-KAN

YL1701

net1::HIS3 CDC14-YFP-HIS3 RRN3-LEU2 GALS-ESP1

YL161

net1::HIS3 CDC14-YFP-HIS3 RRN3-LEU2 cdc15-2 CLB2-MYC-TRP1

YL1702

net1::HIS3 NOP1-DsRed-HIS3 RRN3-LEU2 CDC14-YFP-HIS3

YL174

net1::HIS3 CDC14-YFP-HIS3 RRN3-LEU2 ura3::DsRed-NLS-URA3 cdc15-2 CLB2-MYC-TRP1

YL0932

cdc20::MET-CDC20-TRP1 trp1::6xGAL-ESP1 ura3::GAL-SIC1-4A

393

cdc20::MET-CDC20-TRP1 trp1::6xGAL-ESP1

YL008

esp1::GALS-ESP1-TRP1

YL009

ESP1::GALS-ESP1-TRP1

YL0452

bar1 bub2::HIS3 leu2::GAL-PDS1-mdb-LEU2

OCF1517.2

GAL-PDS1-mdb-LEU2

YL134

cdc20::MET-CDC20-TRP1 clb5::HIS3 ESP1::GALS-ESP1-URA3

YL143

cdc20::MET-CDC20-TRP1 CDC14-TAB6 ESP1::GALS-ESP1-URA3

YL1461

cdc20::MET-CDC20-TRP1 trp1::GALS-CDC14-FLAG-TRP1
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Table 2.1 Continued
YL1462

cdc20::MET-CDC20-TRP1 trp1::GALS-CDC14-FLAG-TRP1 ESP1::GALS-ESP1-URA3

YL169

cdc20::MET-CDC20-TRP1 mad2::URA3 ESP1::GALS-ESP1-URA3 MYO1-GFP-KAN

YL1541

bar1 net1::HIS3 cdc15-2 RRN3-LEU2

YL1542

bar1 net1::HIS3 RRN3-LEU2

YL1722

cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 GAL-SIC1-4A-URA3

YL042

cdc20::MET-CDC20-TRP1 GAL-PDS1-mdb-18MYC-URA3

YL043

cdc20::MET-CDC20-TRP1 GAL-PDS1-18MYC-URA3

2147-3D

pds1::URA3 cdc20::LEU2 ade2::GALL-CDC20-ADE2

YL135

MET-CDC2-TRP1 GAL-SIC1-4A-URA3 PDS1-18MYC-LEU2
MET-CDC20-TRP1

YL1761

ura3::GAL-CLB2kd-URA3

ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3
MET-CDC20-TRP1

YL1851

MYO1-GFP-KanMX
ura3::GAL-CLB2kd-URA3

NET1-mCherry-HIS3

YL1971

ura3::GAL-SIC1-4A-URA3
MET-CDC20-TRP1

MYO1-GFP-KanMX swi5::KanMX
CDC14-YFP-HIS3

ura3::GAL-CLB2kd-URA3

NET1-mCherry-HIS3

MYO1-GFP-KanMX

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3

MYO1-GFP-KanMX CDC5::CDC5pr-GFP-PEST-TRP1
MET-CDC20-TRP1

ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3
MET-CDC20-TRP1

YL2201

NET1-mCherry-HIS3

ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

YL1941

YL2091

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

MYO1-GFP-KanMX CLN2::CLN2pr-GFP-PEST-URA3
MET-CDC20-TRP1

YL2061

NET1-mCherry-HIS3

MYO1-GFP-KanMX
MET-CDC20-TRP1

YL1841

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

MYO1-GFP-KanMX cdh1::LEU2
ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3
MET-CDC20-TRP1

MYO1-GFP-KanMX cdc15-2
ura3::GAL-CLB2kd-URA3

YL2211

MYO1-GFP-KanMX CLB2::CLB2-GFP-HIS3

YL2221

MET-CDC20-TRP1

CDC14-YFP-HIS3

YL2222

CDC14-YFP-HIS3

NET1-mCherry-HIS3

MET-CDC20-TRP1

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

YL2241

MYO1-GFP-KanMX CLB2::CLB2pr-GFP-PEST-LEU2

YL2191

CDC14-YFP-HIS3
MET-CDC20-TRP1

cdh1::LEU2

MYO1-GFP-KanMX bub2::HIS3

ura3::GAL-CLB2kd-URA3

NET1-mCherry-HIS3

MYO1-GFP-KanMX bub2::HIS3

NET1-mCherry-HIS3

MYO1-KanMX

CLB2::GAL-CLB2kd-URA3

cdc5::KanMX

NET1-mCherry-HIS3

ura3::3x(CDC5dB)::URA3

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3

YL2261

MYO1-GFP-KanMX cdc5::KanMX ura3::3x(CDC5dB)::URA3

YL2271

CDC14-YFP-HIS3

NET1-mCherry-HIS3

MYO1-KanMX bub2::HIS3 cdc5::GAL-URL-3HA-CDC5-KaxMX

YL2272

CDC14-YFP-HIS3

NET1-mCherry-HIS3

MYO1-KanMX

YL2291

CDC14-YFP-HIS3

NET1-mCherry-HIS3

MYO1-KanMX bub2::HIS3

YL1961

MATa clb1 clb2::GAL-CLB2

clb3::TRP1 clb4::his3::KanMX clb5::KanMX clb6::KanMX swe1::TRP1

YL1962

MATa clb1 clb2::GAL-CLB2

clb3::TRP1 clb4::his3::KanMX clb5::KanMX clb6::KanMX swe1::TRP1 cdc14-1

MET-CDC20-TRP1
FC015

cdc5::GAL-URL-3HA-CDC5-KaxMX
trp1::2x(GAL-SIC1)::TRP1

ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

NET1-mCherry-HIS3
MET-CDC20-TRP1

MYO1-GFP-KanMX cdc5-1
ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

YL2471

NET1-mCherry-HIS3

YL2491

CDC14-YFP-HIS3

MYO1-GFP-KanMX spo12::KanMX

NET1-mCherry-HIS3

MYO1-GFP-KanMX bub2::HIS3
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cdc16-6A::TRP1

cdc23-A-HA

Table 2.1 Continued
cdc27-5A::KanMX
CDC14-YFP-HIS3
YL2501

NET1-mCherry-HIS3

NET1-mCherry-HIS3
MET-CDC20-TRP1

YL2581

NET1-mCherry-HIS3
MET-CDC20-TRP1

YL2051

sic1::HIS3

cdh1::HIS3

ade2::ADE2::GALL-CDC20
MET-CDC20-TRP1

YL2531

MYO1-GFP-KanMX bub2::HIS3

ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3
MYO1-GFP-KanMX cdc15-2 bub2::HIS3
ura3::GAL-CLB2kd-GFP-URA3,HIS3 adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3
MYO1-GFP-KanMX net1::HIS3
ura3::GAL-CLB2kd-URA3

net1-6Cdk-TEV-myc9-TRP1

adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3

MYO1-GFP-KanMX (p)CDC5-GFP-LEU2
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NET1-mCherry-HIS3

Time course experiments
For alpha factor block, 100nM alpha factor was used. For hydroxyurea (HU)
block, 0.16M HU was used.

In both cases, cells were washed 3 times by

centrifugation and resuspension in fresh media for release.

Arresting the

MET3-CDC20 cell in metaphase was done by addition of methionine to culture
medium, as described (Uhlmann et al., 2000), and release was done by centrifugation
and resuspension in fresh medium lacking methionine. 15μg/ml nocodazole and
10μg/ml benomyl were added to cultures for spindle depolymerization (note: in
Figures this is referred to as ‘NOC’; we found that adding benomyl as well was
important for obtaining a stable block).

Protein extraction, immunoblotting and

Clb2-associated H1 kinase assay were performed as previously described (Wasch and
Cross, 2002).

DNA flow cytometry was performed as previously described (Epstein

and Cross, 1992).

Budding was assessed by microscopic observation. Nuclear

content was assessed by examining samples with nuclei stained with propidium iodide
by fluorescence microscopy.

Growth curve including cell density and mean cell

volume was obtained using a Beckman Coulter Z2 Coulter Counter. The final carbon
source concentration was, Glucose: 2%, Galactose: 3%, Raffinose: 3%. The
MET-CDC20 block experiment in Figure 3.1 was performed in YEP medium,
otherwise in SC medium.

The hydroxyurea and alpha factor block and release

experiments were performed in SC medium. The alpha factor block and release
experiments was performed in YEP medium.
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The time course experiment in Figure

3.3 was performed in YEP medium.

When making a time-lapse movie, only SC

medium was used.

Time-lapse and fluorescence microscopy
For time-lapse microscopy, cells were prepared as described in (Bean et al., 2006).
We used a Leica DMIRE2 inverted fluorescence microscope equipped with an
environmental chamber and objective heater to observe the growth of the yeast cells
at various temperatures.
Orca-ER camera.

Images were acquired every 3 minutes with a Hamamatsu

We used custom Visual Basic software integrated with

Image-Pro5.0 for microscope control and image acquisition. For still-image
fluorescent microscopy, cells were fixed with 4% paraformaldehyde for 10 minutes
before microscopy.

For DAPI staining, cells were treated briefly with 30% ethanol

following the paraformaldehyde fixation step, and stained with 100μg/ml DAPI. For
imaging these cells, we used a Zeiss Axioplan2 fluorescent microscope with a
Hamamatsu C4742-95 camera.
image acquisition.

Openlab5.0 was used for microscope control and

Three Z-stacks at 0.6 micron intervals were taken for each

fluorescent channel and projected onto a single image per channel.

Pulse-expression of GAL1-CLB2kd(-GFP) in MET3-CDC20 blocked cells was
described in Drapkin et al. (submitted). After Clb2kd expression, cells were
immediately transferred to glucose medium without methionine at 30℃ to take
fluorescent pictures every 3 minutes unless otherwise mentioned.
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To measure the

peak level of endogenous Clb2-GFP, MET3-CDC20 CLB2-GFP cells were grown up
in glucose medium without methionine, and transferred into glucose medium with
methionine to take time-lapse series. Clb2-GFP level at MET3-CDC20 blocked cells
was divided by 2 after background subtraction to be the peak Clb2-GFP in cycling
cells; A population average was taken (the two-fold relationship between peak
Clb2-GFP in cycling cells and that in MET3-CDC20 block was established in Drapkin
et al. submitted).

Image analysis
Time-lapse movie segmentation and analysis was done using custom software as
described in (Charvin et al., 2008). For the analysis of fluorescent microscopy
pictures and r value calculation, we designed custom software in the Matlab
environment. The Z-stack with the highest signal standard deviation was chosen for r
value calculation. r value was calculated by taking the average CDC14-YFP
intensity of the brightest 5% pixels within a cell area, and subtracting the average of
the dimmest 5% pixels; this value was then divided by a similar value for the
NET1-CFP signal.

In Chapter 4, we quantify Cdc14-YFP release by taking the coefficient of
variation (CV, standard deviation divided by mean) of Cdc14-YFP pixel intensities
inside a cell (mother and bud are treated separately), and divided by the CV of
Net1-mCherry.

Bud emergence was detected visually; Cytokinesis was detected
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using Myo1-GFP (in case Myo1 ring shrinking was slowed down by Clb2kd, we
recorded the time when Myo1 ring shrinking was competed.); Nucleolar separation
was defined as the initial stretching of Net1-mCherry signals, followed by a full
separation in 3~6 minutes. A narrow band-width GFP filter (Chroma, 41020) allows
for detection of GFP signals with little intervention from YFP spectrum.
Subsequently, the GFP portion was subtracted from original YFP images to restore
pure YFP images.

Control experiments with single-labeled cells (data not shown)

indicate that this method yielded reliable quantifiable images without significant
effective bleed-through between channels. Bud-neck regions were always excluded
from quantification since Cdc14-YFP can also localize during ME. SPB signaling of
Cdc14-YFP was detected by identifying bright YFP pixels whose underlying mCherry
signals were low.

Those pixels, if scored, were excluded from quantification, but did

not cause any difference to our conclusions(Lu and Cross, 2009). In net1Δ
net1-6Cdk cells in Figure 4.14, Cdc14 release was quantified by taking 3 Z-stacks
with 2 micron intervals. And CV(Cdc14-YFP) in the best focused Z-stack was used
to qualitatively reflect Cdc14 localization.

Data analysis.
All data analysis was performed using Matlab. Fluorescence time-lapse series
were extracted from movies as previously described(Charvin et al., 2008).
Smoothing is performed using 3-neighbour averaging method. Because Clb2(kd)-GFP
primarily localizes to the nucleus, we took the average GFP intensity of the brightest
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10% pixels in a cell and divided it by the square root of the cell area to be the
effective Clb2(kd)-GFP concentration (average over the first 5 frames).

Clb2kd

concentration by this measure correlated best with graded ME delays. Average GFP
intensity in a cell was used to measure transcription using promoter-GFP-Pest
fusions(Bean et al., 2006).

Simulation of Kuramoto oscillator population with central
pace-makers.
Kuramoto oscillator networks containing 100 nodes were generated. The
dynamics of the ith node was driven by equation dϕi = ωi + λ ∑ ai , j sin(ϕ j − ϕi ) ,
dt

j

ai , j ∈{0,1} is the interaction matrix; λ is the coupling strength. Network

connections was either completely randomly established or using preferential
attachments, and always kept the average in-degree <kin> and out-degree <kout> equal
to 2.0 (i.e. on average, each node received 2 interactions and sent out 2 interactions).
In preferential attachments(Barabasi and Albert, 1999), a network was grown from a
small seed (N=2), and was gradually added nodes and links to it . For each node in the
preexisted network, its chance of getting a new connection is in proportion to k α ( k
is its degree;

α is the preferential exponent). Preferential attachment was only

applied to out-links. We scanned the coupling strength λ from 0.1 to 3.0 with 100
increments. For each λ , we randomly generated 1000 network connections with
randomly chosen intrinsic frequencies ωi ∈ [−1,1] and initial conditions

ϕ 0i ∈ [−π , π ] . R = 1

N ⋅T

T

∫

0

N

| ∑ e iϕi | dt (T=100, N=100) was used as the order parameter
i =1
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to represent the degree of entrainment. All simulation was programmed in C language
with Numerical Recipe 2.0 package.

The conceptual model of phase-locking.
The kinetics of the peripheral oscillator P and the Cdk oscillator C is governed by
simple oscillator equations.
phase-locking.
dϕ C
dϕ P

The free-running C can affect P’s frequency to establish

Theirs phases evolve as:

dt

= ωC

dt

= ω P + A * Z (ϕ P ) sin(ϕ C )

(A: amplitude of C, Z (ϕ P ) : P’s frequency response

function). For simplicity, we assume
⎧⎪
Z
Z (ϕ P ) = ⎨ 0
⎪⎩ 0

5
(ϕ P ∈ [0, π ] + 2kπ ,
7
(otherwise )

k = 1,2,3...)

In Figure 4.19B, the frequency of Cdk oscillator ω C = 1.0 is a constant.
Frequencies of the 3 peripheral oscillators ω P =[0.8 0.3 1.4], which roughly
corresponds to budding, SPB duplication and Cdc14 release oscillator. And Z0=[1.0
7

1.7] respectively. Cdk oscillation amplitude A=1.0.

ϕ C (t = 0) = ϕ P (t = 0) = 0.
Figure 4.19B.

Initial condition

In Figure 4.20A, let A=0.85, otherwise, identical to

Simulation was done using Matlab.

ODE simulation of Cdc5-Cdc14-Cdh1 negative feedback
model
Equations:
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d [Cdc5]
= a cdc 5 * clb2
v
dt
(clb 2 + k clb 2 ) − d cdc 5 * [Cdc5] − [Cdh1][Cdc5] * cdc 5

([Cdc5] + k cdc 5 )

d [Cdc14]
v
= (cdc14T − [Cdc14]) * [Cdc5]n * cdc14
* [Cdc14]
n −d
([Cdc 5]n + k cdc14 ) cdc14
dt
v
v
d [Cdh1]
= (cdh1T − [Cdh1]) * [Cdc14] * cdh1 p
− clb2 * [Cdh1] * cdh1 pp
(cdh1T − [Cdh1] + k cdh1 )
(k cdh1 + [Cdh1])
dt

Parameters
a cdc 5 = 1.0
cdc14T = 0.2
cdh1T = 0.5

k clb 2 = 1.0
v cdc14 = 10
v cdh1 p =1.3

d cdc 5 = 0.15

v cdc 5 = 8.0

k cdc14 = 1.0
v cdh1 pp = 0.15

k cdc 5 = 0.015

d cdc14 = 0.8

n=3

k cdh1 = 0.6

Parameter clb2 stands for Clb2kd concentration (/peak). In Figure 4.13E, clb2=1.0;
Initial condition=[0 0 0].

Simulation was done using Matlab.

Calculation of Cdc14 release and SPB timing using
phase-locking model
Assume a peripheral oscillator P (such as bud emergence, SPB duplication, Cdc14
release…) oscillates at frequency f P

A

at a specific locked Clb-Cdk level A (Any

such level can be chosen provided it is permissive for oscillations of P).

Also

assume the Clb-Cdk oscillator C oscillates at a constant frequency f C (i.e. the
frequency of cell cycle). Clb-Cdk activities above or below A could change the
instantaneous frequency of P by the amount Δf = Z (ϕ ) SC , where SC is Clb-Cdk
activity relative to the reference A ( SC = Clb − A ), and Z (ϕ ) is the phase response

curve of P to Clb-Cdk activity, and is in general a function of P’s phase ϕ .

According to experiments in Figure 4.10, only the inter-release period (from the
end of last release to the beginning of the next) was reduced as Clb2kd level increased,
but not the duration of Cdc14 release or release amplitude. This observation will
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restrict Z (ϕ ) to the following form:
⎧Z (ϕ < ϕ0 )
Z (ϕ ) = ⎨ 0
, ϕ ∈ [0,2π )
⎩0 (ϕ ≥ ϕ0 )

In the unidirectional model, we ignore the feedback from P to C, and assume that
Clb-Cdk activity oscillates as a function 0.5 * (1 + sin(ϕ + ψ )) , where ψ is the phase
difference between P and C. (The simple sin(ϕ + ψ ) function is altered by these
arithmetic operations just to avoid biochemically nonsensical ‘negative’ Clb-Cdk
activity, and to keep Clb-Cdk values between 0 and 1, where 1 corresponds to ‘1X
peak’ in our experiments; see main text).

To constitute an actual cell-cycle, P and C must oscillate with identical frequency
averaging over each cell cycle and a stable phase difference. So we first look for the
condition where the original frequency difference f C − f P

A

between C and P is

compensated by Clb-Cdk oscillation. i. e. we look for a phase difference ψ
satisfying the following equation:
A

f C − f P =< Δf >ϕ =

1
2π

∫

2π

0

Z (ϕ )(0.5 ⋅ sin(ϕ + ψ ) + 0.5 − A)dϕ

This formulation implies that at any instant, Clb-Cdk can either advance or retard the
velocity of P through its cycle, depending on the coincidence of Z0 with Clb-Cdk
above or below A.
The above equation can be solved to yield:

ψ = sin −1 (

( f C − f P + ( A − 0.5) < Z (ϕ ) > 2π )2π
) − ϕ0 / 2
Z 0 sin(ϕ 0 / 2)
A
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Note: In general, ψ is also a function of ϕ . To obtain analytical results, we do the
integration by approximating ψ to a constant, meaning that the phase of P still
progress smoothly. This approximation is exact when f C − f P

A

and Z (ϕ ) are

small (Winfree, 1967). Simulations with an ODE model show that with Z0, f C and
fP

A

in the range of our empirically determined values (see below), Z0 and f C − f P

A

are small enough that this approximation is extremely close to the exact value (data
not shown).

Different phase-response curves Z (ϕ ) will yield different stable solutions for

ψ : therefore, oscillators entrained by different Z (ϕ ) will cycle at different phases
relative to the Clb-Cdk oscillator, potentially ordering cell cycle events.

It’s demonstrable that the calculation of ψ is independent of the choice of
A

reference point A. f P is approximately a linearly function of constant Clb2kd levels
A

A below 1.7xPeak (Figure 4.10B). Therefore, we write f P = k * A + B . k is the

slope of the linear fitting in Figure 4.10B, which is equal to average Z (ϕ ) over one
cycle ( k =< Z (ϕ ) > 2π ). Then

ψ = sin −1 (

( f C − B − 0.5 < Z (ϕ ) > 2π )2π
) − ϕ 0 / 2 , independent of A.
Z 0 sin(ϕ 0 / 2)

For the convenience of calculation, the Clb-Cdk reference point is set at A=0.5.
(MATLAB code for running this and related simulations are available upon request;
we have found these simulations very helpful for aiding intuition).
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The duration of Cdc14 release is approximately 20 minutes. From Figure 4.10,
we estimate the period of the Cdc14 release oscillator at 1X peak Clb2kd at 70
minutes, then we obtain ϕ0 =

10
π (For the Cdc14 oscillator, ϕ = 0 corresponds to
7

the completion of Cdc14 resequestration). For the estimation of < Z (ϕ ) > 2π (i.e. the
slope of fitting in Figure 4.10B), we use only ‘category 3’ cells as defined in Figure
4.10B, since only these cells allow an unambiguous interpretation as ‘endocycling’.
We estimate Z 0 =

2π

ϕ0

−1

< Z (ϕ ) > 2π , and obtain Z 0 = 0.022 ± 0.006 ( PeakClb 2 ⋅ min −1 ) .

When calculating Cdc14 entrainment phase, we took A = 0.5 as the reference
point of stable Clb-Cdk, so that f P

A

is estimated at approximately the average

Clb-Cdk activity in a cell cycle When Clb2kd<1X peak, the Cdc14 release oscillator
is entrained or partially entrained into cell cycle due to endogenous Clb-Cdk
oscillation, because at these low levels of Clb2kd, mitotic exit occurs and endogenous
cyclin accumulates to sub-peak levels (data not shown). For this reason, we lack
endocycle data at Clb2kd=0.5, and we are obliged to linearly extrapolate the
frequency response of Cdc14 release oscillator in Figure 4.10B to 0.5X peak Clb2kd.
We obtain f P

A −1

= 95 ± 15 (min .) . For the frequency of Clb-Cdk cycles in wild-type
−1

mother cells, we take f C = 80 (min .) based on abundant and reliable data for cycling
wild-type cells (data not shown). Since f P

A

and Z 0 measurements contain

substantial uncertainty, we calculate ψ at the average, +/- one standard deviation for
each, summarized in the following table, and plotted below together with modeled
Clb-Cdk levels (see Figure 4.20C legend):
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0.017

0.0224

0.028

80

-0.71π

-0.71π

-0.71π

95

-0.33π

-0.47π

-0.52π

110

No solution

No solution

-0.30π

Z0 (Peak−1⋅min−1)
fP-1 (min.)

(The lack of a solution in two cells of the table is likely due to oversimplifications in
the model, such as describing Z (ϕ ) as a step function, which results in unrealistically
tight boundary conditions).

We next consider the phase-locking between SPB duplication oscillator and
Clb-Cdk oscillator. This demonstration can be based only partially on empirical data,
because in particular there is no quantitative information on the period of the SPB
re-duplication cycle as a function of Clb levels. According to previous studies, there
is a licensing period following SPB separation when SPB reduplication is inhibited by
high Clb-Cdk activity, but not in other parts of the SPB duplication cycle. Therefore
according to our formulation, Z 0 < 0

within the licensing period, Z 0 = 0

elsewhere. In cycling cells, the licensing period starts from SPB maturation in G2
until the next G1. For a typical cell cycle of 80 minutes (for mother cells), G1 lasts
for ~20 minutes; S phase lasts for ~15 minutes. Therefore the licensing period is ~45
9
minutes, and we have ϕ0 = π ( ϕ = 0 corresponds to the beginning of the licensing
8
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period, since by convention we set the beginning of the cycle to be the beginning of
the part of the cycle affected by Clb2).

While free oscillation of SPB duplication and cell-cycle-regulated transcription
have been established, there is insufficient data to obtain empirical estimates of Z (ϕ )
A

and f P . The fact that SPB duplication is always entrained with cell cycle in wild
A

type cells indicates that ( f C − f P ) / Z 0 should be small, which is easy to obtain
with a large Z 0 . Consistently, having Clb4 as the only mitotic cyclin completely
blocks SPB reduplication (Haase et al., 2001), implying that the frequency of SPB
oscillator is sensitive to Clb-Cdk levels, suggesting a large Z0. Therefore, we could
A

assume ( f C − f P ) / Z 0 ~0, and obtain

ψ =π −

ϕ0
2

=

7
π
16

(the ψ = −

ϕ0
2

=−

9
π solution is dynamically unstable due
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to Z 0 <0) (Winfree, 1967).

The stable solution restricts SPB duplication and maturation to the rising-phase of
Clb-Cdk oscillator, roughly corresponding to G1 Æ G2, which is physiologically
meaningful. (See Figure 4.20 legend)

Proof of linearity for the metric used to quantify Cdc14
release
At Cdc14 fully sequestered state:
O0 = N 0 + S0 :

where O is the observed signal, S is the real Cdc14 - YFP signal, and N is noise.
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When there is a fraction (1-λ) of Cdc14 released and become a uniform background C
O1 = N 1 + S1 + C = N 1 + λ S 0 + C

Assuming that Net1-mCherry is always nucleolar, and when Cdc14 is fully
sequestered, Cdc14 totally colocalizes with Net1:
CV (O1
) 2
CV (O1
) 2 Var (O1
) λ2Var ( S0 ) + Var ( N1 )
)
=
(
)
=
=
Net 1
Cdc14
Cdc14
CV (O1 )
CV (O0
)
Var (O0
) Var ( S0 ) + Var ( N 0 )
Cdc14

r2 = (

Cdc14

Cdc14

The last step is obtained by assuming no covariance between Cdc14 signal and
background noise.
cov(S0 , N1 ) = cov(S0 , N 0 ) = 0

We can see that, even when Cdc14-YFP is completely released, λ=0, r is still >0
due to background fluctuations.

The bidirectional phase-locking model
Cdc14 is not a simple peripheral oscillator, since it regulates Clb-Cdk activity
(see main text). Therefore, in a full account, it should be necessary to take mutual
entrainment into account. The fact that initial Cdc14 release and resequestration
occur with normal kinetics at all levels of Clb2kd (main text) suggests, however, that
the bidirectionality is not highly important in determining phasing of Cdc14 release
relative to peak Clb2.

To construct a bidirectional model, we adopt all basic assumptions in the
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unidirectional model; in addition, assume there is also a feedback interaction from a
peripheral oscillator P to the Cdk oscillator C. We named the coefficient of the
interaction from C to P as Z C − > P (ϕ ) , and the one from P to C as Z P − > C (ϕ + ψ ) , then
the steady state condition reads
< f P >ϕ =< f C >ϕ Æ

f C + < Z P − > C (ϕ + ψ ) S P >ϕ = f P + < Z C − > P (ϕ ) SC >ϕ

Also consider
⎧Z (ϕ < ϕ0 )
ZC −> P = ⎨ 0
⎩ 0 (ϕ ≥ ϕ0 )

In the case of Cdc14-release oscillator, we can get an analytical solution by
assuming whenever there is Cdc14 release in a cell-cycle, there will be activation of
Cdh1/Sic1 to inactivate Clb-Cdk, then we have Z P − > C (ϕ + ψ ) = constant. Therefore
< Z C − > P (ϕ ) SC >ϕ = f C − f P +

1
2π

∫

2π

0

Z P − > C (ϕ + ψ ) S P dϕ = f C − f P + Λ , ( Λ is a constant)

Then
1
2π

∫

ϕ0

0

Z 0 (0.5 ⋅ sin(ϕ + ψ ) + 0.5 − A)dϕ = f C − f P + Λ

Solve it to get
ψ = sin −1[( f C − f P + Λ + ( A − 0.5) < Z (ϕ ) > 2π )

2π
Z 0 sin

ϕ0

]−

ϕ0
2

2

f C − f P + Λ needs to be determined experimentally.
Z0

Due to the unknown parameter Λ , ψ calculated using the bidirectional model
can be different from the unidirectional model. But the same general conclusions hold
for both models, such as 1. There will be at least one stable phase-locking solution ψ
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giving strong enough coupling Z0; 2. Cell cycle oscillators with different
phase-response curve Z (ϕ ) could oscillate at different ψ , which may order the cell
cycle.
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Chapter 3: Mitotic Exit in The Absence of
Separase Activity
1. Background information
Mitotic Exit (ME) is a complex set of events encompassing spindle disassembly,
cyclin inactivation, cytokinesis and relicensing of replication origins. In budding
yeast Saccharomyces cerevisiae, the phosphatase Cdc14 is required for ME. A first
wave of Cdc14 release has been described in early anaphase, controlled by the
separase-induced FEAR (cdc Fourteen Early Anaphase Release) network which
includes separase (Esp1), Spo12, Slk19, Cdc5 (Stegmeier et al., 2002). After DNA
replication in S phase and kinetochore attachment, activated APC-Cdc20 commits the
cell to chromosome segregation in anaphase by inducing the degradation of B-type
cyclins and securin Pds1 to promote the onset of anaphase.

Pds1 forms a complex

with Esp1, serving as its chaperone, and also inhibiting Esp1 proteolytic activity.
After Pds1 proteolysis, free Esp1 may down-regulate phosphatase PP2A (Queralt et
al., 2006), enhancing Net1 phosphorylation and promoting transient Cdc14 release
(the FEAR network mechanism).

FEAR-released Cdc14 modulates nuclear

movement, rDNA segregation and spindle stability before ME (Azzam et al., 2004).
In later anaphase the release status of Cdc14 is maintained by a second mechanism,
the Mitotic Exit Network (MEN), which involves Tem1, Cdc15, Dbf2/Mob1 and its
inhibitor Bub2/Bfa1.

MEN activation may be due to Cdc14-dependent Cdc15

dephosphorylation, spindle-elongation-induced Tem1 activation, or
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Polo-kinase-induced Bub2/Bfa1 inactivation (Bardin et al., 2000; Hu et al., 2001;
Jaspersen and Morgan, 2000).

Current concepts place separase Esp1 at the center of ME regulation. A
non-proteolytic function of Esp1 is considered responsible for early anaphase release
of Cdc14, perhaps to promote Cdc15 dephosphorylation to activate MEN. MEN
activity can promote additional Cdc14 release, thus forming a potential positive
feedback loop, which could eventually release enough Cdc14 to drive ME.

Although these concepts are supported by much experimentation, the ME system
is highly complex, with interdigitated control networks making experimental design
challenging, and straightforward interpretation sometimes difficult.

I attempted a

factorial approach (Fisher, 1935) of independently controlling CDK inactivation, the
non-proteolytic function of Esp1, and spindle elongation, aiming to achieve a
balanced view of the relative contributions of three major regulators in ME. These
experiments have led me to a view of ME emphasizing the importance of CDK
inactivation and activation of the MEN as the primary drivers. In contrast to the
proposal of a protease-independent essential role for Esp1 in ME, my results suggest
that the primary contribution of Esp1 in ME is to promote sister chromatid separation,
which leads to spindle-elongation-dependent MEN activation.
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2. Factorial control of mitotic exit

Complete factorial design of experiments employs systematic combinations of a
set of controlling factors.

This approach allows determination not only of the

contribution of each individual factor but also of interactions between them (Fisher,
1935). It is especially suitable and efficient for studying a complex system like the
ME pathway for which I have little quantitative knowledge about the independence of
its components.

I chose three factors known to contribute to ME: Esp1 activation, cohesin
cleavage and consequent spindle elongation, and CDK inactivation, as control points
of the system (Figure 3.1A). CDK inactivation, by degradation of mitotic cyclins
such as Clb2, is essential for ME (Wasch and Cross, 2002). Another essential player
that has been proposed is the non-proteolytic function of Esp1, which promotes
spindle stability and FEAR network activity; however, the FEAR network has been
found to be dispensable for ME in most studies (Jensen et al., 2001; Queralt et al.,
2006; Stegmeier et al., 2002).

My third factor, cohesin cleavage and consequent

spindle elongation, activates MEN by promoting interaction of the daughter spindle
pole body with the bud cortex (Bardin et al., 2000; Yeh et al., 1995). Spindle
elongation also creates the spindle mid-zone, a signaling center for Aurora kinase and
the NoCut pathway (Norden et al., 2006).
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A critical requirement for my approach is availability of tools to separately and
independently manipulate those inputs.
approaches to control each factor.

Wherever possible, I have used multiple

I prevent CDK inactivation in most experiments

by blocking APC activation, using MET3-CDC20 strains incubated in methionine
medium.

Conversely, I can promote CDK inactivation by over-expressing

unphosphorylatable Sic1 from a galactose inducible promoter (GAL1-SIC1-4A)
(Verma et al., 1997) or in some experiments by relying on the endogenous cyclin
degradation system driven by the APC.

I control the presence of active Esp1 in most

experiments by expressing undegradable Pds1 (Cohen-Fix et al., 1996), either from
strong ectopic promoters or expressed from its endogenous locus.

I control spindle

elongation independently of Esp1 by bypassing the Esp1 requirement for cohesin
(Scc1) cleavage, using the TEV-Scc1-TEV-site system of Uhlmann et al. (Sullivan
and Uhlmann, 2003; Uhlmann et al., 1999), or the scc1-73 temperature-sensitive
allele (Michaelis et al., 1997).

Alternatively, in the presence of Esp1 I independently

block spindle elongation using nocodazole, or MEN activation using the cdc15-2
temperature-sensitive mutation.

Independence of these perturbations (that is,

altering one input should not indirectly affect the others) is generally expected from
the literature, and confirmed in my experiments wherever possible; however,
complete independence of input modules can only be reached approximately.
Therefore, I have strengthened my conclusions by alternative experimental designs
for testing the same effective factor combinations wherever possible.
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Figure 3.1. Combinatorial control of mitotic exit by Cdk inactivation and cohesin
cleavage, in the absence of Cdc20. A. Major components and interactions in ME
system; arrows: induction; bars: inhibition. Components indicated in red are exterior
control points used here to manipulate the system. B. Cultures of MET3-CDC20 strains
were first arrested in metaphase at 23°C by incubation in raffinose+methionine medium
to deplete Cdc20, then galactose was added to the cultures to induce the expression of
GAL1-TEV and GAL1-SIC1-4A where present. Methionine was kept in the medium
throughout to maintain cdc20 depletion, except for the experiment labeled ‘control’,
which was released into galactose medium lacking methionine to re-induce Cdc20. Strain
genotypes: 1. “control”, MET3-CDC20 GAL1-SIC1-4A (YL1721). 2. “+ +”,
MET3-CDC20 scc1Δ SCC1-TEV GAL1-TEV GAL1-SIC1-4A (YL353). 3. “+ –”,
MET3-CDC20 scc1Δ SCC1-TEV GAL1-TEV (353). 4. “– +”, MET3-CDC20
GAL1-SIC1-4A (YL1721). 5. “– –”, MET3-CDC20 (BD96b-4C). + +, + –, – + or – –
indicate the presence or absence of GAL1-TEV/SCC1-TEV and GAL1-SIC1-4A. The
fraction of large budded cells (excluding rebudded and small budded cells) was calculated
from >200 cells at each time point.

DNA flow cytometry profiles from the beginning

and end of the time course for each sample are shown (complete DNA flow cytometry
data in Fig. 3.2), as well as sketches of the cell morphologies at the end of the experiment.
Note that the elongated buds are a consequence of rebudding (with or without prior
cytokinesis) in the presence of high Sic1 levels (Lew and Reed, 1993), and thus allow
unambiguous discrimination between the large round buds found at the beginning of the
experiment and the new buds formed after complete or partial mitotic exit.
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Figure 3.1
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In the first series of experiments (Figure 3.1B), cells were arrested in metaphase
using a methionine-suppressible MET3-CDC20 construct (Sullivan and Uhlmann,
2003). Cdc20 is an essential activator of the APC, and in its absence cells arrest with
high CDK activity due to mitotic cyclin stabilization (Yeong et al., 2000).

In

addition, the Cdc20 target Pds1 accumulates at high levels, and anaphase is blocked
due to Pds1 inhibition of Esp1 (Shirayama et al., 1999); therefore, I assume that Esp1
activity is limited or absent.

I then examined if these cdc20-blocked cells can carry

out mitotic exit, as a function of ectopic regulation of anaphase using the
GAL1-TEV/SCC1-TEV system (Uhlmann et al., 2000), and of ectopic Clb-Cdk
inactivation using GAL1-SIC1-4A (Verma et al., 1997).

To monitor ME, I employed

phase contrast microscopy to detect cell division and budding, and DNA flow
cytometry to analyze replication and effective chromosome segregation to daughter
cells (implying cytokinesis and cell separation). I were surprised to observe that
simultaneously providing ectopic sources of cohesion cleavage and Clb-Cdk
inactivation allowed quantitative and rapid mitotic exit, by the assays of cytokinesis,
nuclear division and rebudding in the next cell cycle (Figure 3.1B), resulting in the
efficient accumulation of 1C budded cells. Of the two factors driving ME in this
remarkably effective synthetically driven ME, CDK inactivation is essential, while
TEV-mediated cohesin cleavage and consequent spindle elongation is important for
efficiency but not absolutely required (Figure 3.1B).

This experiment resembles one published by Sullivan and Uhlmann (2003),
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except that in that work, clb5 deletion was employed for Clb-Cdk inhibition, which is
very likely to provide only partial decrease in Clb-Cdk activity (as evidenced by
viability of clb5 cells), while in contrast, GAL1-SIC1-4A quantitatively eliminates all
Clb-Cdk activity and results in complete inviability (Figure 3.2B).

Strikingly, timing of mitotic exit in the GAL1-SIC1-4A GAL1-TEV cdc20 cells
was similar to that of cells released from the cdc20 block (Figure 3.1B, + + v.s.
control). I assume that Esp1 was effectively inhibited by persistent Pds1 due to the
cdc20 block, since anaphase was completely inhibited without GAL1-TEV expression.
Therefore, these results suggest that ESP1 does not play a major role in ME besides
its function in sister chromatid separation and the resulting spindle elongation.

I further assessed the role of separase in ME in this protocol using a
proteolytically inactive mutant ESP1C1531A (Uhlmann et al., 2000).

I constructed a

MET3-CDC20 strain that contained the rapidly inactivatable esp1-2td allele (Queralt
et al., 2006) as well as GAL1-SIC1-4A to allow Clb-Cdk inactivation and a copy of
ESP1C1531A under control of the endogenous promoter.

As expected, release of the

cdc20 block did not lead to anaphase in this strain. Employing the same set of assays
for ME, I saw only the same partial mitotic exit phenotype that I could attribute to
GAL1-SIC1-4A (Figure 3.1), with no detectable contribution from ESP1C1531A (Figure
3.2).
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Figure 3.2. A. DNA flow cytometry profile for time-courses in Figure 3.1. B.
MET-CDC20 6xGAL-ESP1 (393) or MET-CDC20 6xGAL-ESP1 GAL-SIC1-4A
(YL0932) was arrested in metaphase at 23° by incubation in raffinose+methionine
medium to deplete Cdc20.

3% galactose was added to the culture at time zero. Clb2

kinase assay, done as described in Materials and Methods, showed that GAL-SIC1-4A
induction almost completely eliminated Clb2 kinase activity after 1 hour induction. C.
MET-CDC20 esp1-2td GAL-UBR1 ESP1-C1531A GAL-SIC1-4A (YL094, separase +)
was arrested at 25° by depleting Cdc20, followed by temperature shift to 37° to
inactivate esp1-2td, and then Cdc20 was reintroduced by transferring to galactose
medium lacking methionine. MET-CDC20 GAL-SIC1-4A (YL172, separase –) and
MET-CDC20 (BD96B-4C, control) are described in Figure 3.1.
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Figure 3.2
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3. Endogenous undegradable Pds1 blocks sister-chromatid
separation

I wanted to confirm that endogenous levels of Pds1 could effectively block Esp1
activity in the absence of Cdc20-dependent Pds1 degradation, since this was an
important assumption in the experiments described above. Inviability of endogenous
levels of Pds1-mdb was suggested by failure to recover transformants of PDS1-mdb
under control of the PDS1 promoter in low-copy number plasmids (Cohen-Fix et al.,
1996), but the reason for the failure to recover these transformants was not elucidated.
I constructed a PDS1-mdb allele at the endogenous locus, using exact gene
replacement.

The potential lethality of this allele was overcome by mildly

over-expressing Esp1 under a truncated GAL1 promoter (Mumberg et al., 1994),
GALS-ESP1.

Indeed, this strain is fully viable on galactose media but inviable on

glucose (Figure 3.3A), confirming that endogenous levels of undegraded Pds1 were
lethal, specifically because of Esp1 sequestration.

Pds1-mdb was stable through the

cell cycle at endogenous levels, while Pds1-wt was degraded before anaphase as
expected (Figure 3.3B). Since Esp1 is a stable protein, transcriptional repression of
GALS-ESP1 by glucose in a PDS1-mdb background allows two or more near-normal
cell cycles. Subsequently, I observe a gradual increase of unseparated chromosome
dots (Bachant et al., 2005) (Figure 3.3C) and a gradual increase of large budded cells
with 2C DNA content (Figure 3.4A).

These cells were highly delayed in ME,

although ultimately most cells underwent aberrant mitosis with generation of
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aneuploid or aploid cells (Figure 3.4A). From these results, I conclude that the
endogenous level of Pds1 can effectively inhibit Esp1 and block sister-chromatid
separation, provided its Cdc20-mediated degradation is blocked.
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Figure 3.3. Endogenous undegradable Pds1 blocks sister-chromatid separation.
A. PDS1-mdb ESP1::GALS-ESP1 (YL018) or a wild-type control were plated by 10x
serial dilution on either glucose (D) or galactose (G) plates at 30° to assess viability. B.
Cultures (PDS1-mdb-myc ESP1::GALS-ESP1 or control PDS1-wt-myc) synchronized
by alpha-factor block-release were assayed by Western blotting with anti-Myc
antibody. Pgk1 western blot was employed as a loading control. C. Endogenous Pds1
is sufficient to block sister-chromatid separation. Glucose was added to
galactose-grown mid-log cultures of PDS1-mdb trp1::LacO LacI-GFP, containing
either esp1::GALS-ESP1 (YL115, filled bar) or ESP1::GALS-ESP1 (YL113, hatched
bar).

Samples were fixed with paraformaldehyde and examined by fluorescence

microscopy to score separation of the GFP-labeled chromosome ‘dots’. Fraction of
large budded cells with unseparated GFP dots (red), with well-separated GFP dots
(green) or closely separated GFP dots (blue) are shown. Cell morphologies at the
beginning and end of the experiment in the various conditions are diagrammed in the
cartoons.
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Figure 3.3
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Figure 3.4

Figure 3.4. A. DNA flow cytometry profile: PDS1-mdb esp1::GALS-ESP1 (YL114)
cells were grown to log phase in galactose media, then 2% glucose (Glu) was added at
time zero. B. Growth curve: PDS1-mdb esp1::GALS-ESP1 (YL114) and PDS1-mdb
ESP1::GALS-ESP1 (YL018) and esp1::GALS-ESP1 (YL008) strains growing in
glucose or galactose. Cell density and mean cell volume were measured as described
in Materials and Methods.
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4. Inhibition of Esp1 by overexpression of overexpression of
undegradable Pds1 blocks ME via blockage of cohesin
cleavage

Overexpression of undegradable Pds1 causes a complete block to anaphase, and a
many-hour delay in ME (Cohen-Fix et al., 1996; Queralt et al., 2006; Sullivan and
Uhlmann, 2003).

Consistently, in my experiments in Figure 3.1, Cdc20 depletion

(leading to Pds1 accumulation and Esp1 inhibition), led to a significant delay in ME
even when Clb-Cdk inhibition was provided ectopically by GAL1-SIC1-4A.
However, this delay was efficiently rescued by ectopic cohesin cleavage using
GAL1-TEV (Figure 3.1B), suggesting that most of the delay was due to failure of
cohesin cleavage.

I were concerned, though, that I had not achieved complete Esp1

inhibition using endogenous levels of accumulated Pds1.

To ensure that I achieved

full inactivation of endogenous Esp1, I overexpressed Pds1-mdb from the GAL1
promoter.

I expressed GAL1-PDS1-mdb expression for an hour to accumulate

abundant Pds1-mdb in cdc20-blocked cells, and then released the cdc20 block by
methionine removal.

In this protocol, Clb-Cdk inactivation is expected to proceed

via the Cdc20-APC system, while Esp1 is sequestered by Pds1-mdb overexpression.
I provided an ectopic source of cohesin cleavage using the GAL1-TEV/SCC1-TEV
system.

As a control, I carried out the same protocol substituting GAL1-PDS1(wt),

expressing the degradable form of Pds1, for GAL1-PDS1-mdb. Expression of
Pds1-mdb caused no delay in cytokinesis or Clb2 degradation compared to expression
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of Pds1-wt, despite persistence of Pds1-mdb but not Pds1-wt, suggesting that Pds1 is
not an effective ME inhibitor provided the need for the proteolytic activity of Esp1 is
bypassed (Figure 3.5C).

While this experiment provides a direct comparison

between Pds1-wt and Pds1-mdb at equally overexpressed levels, overexpressed
Pds1-wt could delay ME compared to endogenous levels. However, in the
remaining experiments I compared overexpressed Pds1-mdb to endogenously
expressed Pds1-wt.
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Figure 3.5. Endogenous Esp1 is not necessary for efficient mitotic exit. A.
Artificial cleavage of Scc1 with TEV protease ensures efficient ME in the absence of
active Esp1. mad2Δ strains were arrested in S phase at 30°C with 0.16M hydroxyurea,
and released into galactose with alpha factor. Pds1-mdb and TEV protease were
overexpressed from the GAL1 promoter to inactivate Esp1 and to cleave Scc1-TEV
(YL057). Strains lacking GAL1-TEV (YL045) GAL1-PDS1-mdb (YL049), or both
(2151-7B) were used as controls. B. Inactivation of cohesin Scc1 restores the
efficiency of ME in the absence of active Esp1. mad2 GAL1-PDS1-mdb strains, either
scc1-73 (YL044) or SCC1 (YL045) were arrested by alpha factor at 25°C, then
released into the absence of alpha factor either in galactose media to induce
undegradable Pds1-mdb or raffinose as a control. Cultures were released at 37°C to
inactivate cohesin (scc1-73). Alpha factor was reintroduced 1.5 hours post release to
cause accumulation of cells in G1 after ME.

DNA flow cytometry was used to

assess cell cycle progression. C. Pds1-mdb doesn’t independently block ME in cells
provided with ectopic chromosome separation by TEV protease.
GAL1-TEV/SCC1-TEV MET3-CDC20 strains, containing GAL1-PDS1-wt (YL042) or
GAL1-PDS1-mdb (YL043), were arrested at the cdc20 block by incubation in
raffinose plus methionine medium, and then pulsed with galactose plus methionine for
an hour.

The cultures were then transferred into glucose without methionine to

release the cdc20 block.

DNA content was measured by DNA flow cytometry, and

Clb2 protein level by Western blot. Even loading was shown by amido-black staining
(data not shown).
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Figure 3.5
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I confirmed and extended this result using S-phase block with hydroxyurea, with
the four combinations of presence or absence of GAL1-PDS1-mdb and
GAL1-TEV/SCC1-TEV, all in the presence of wild-type endogenous PDS1.

Because

premature cohesin cleavage can activate the Mad2-dependent spindle checkpoint
(Severin et al., 2001), I carried out these experiments in a mad2Δ background.

In

this protocol I allow the endogenous Cdc20-dependent Clb degradation system to
eliminate Clb-Cdk activity and endogenous Pds1.

As previously reported

(Cohen-Fix et al., 1996), Pds1-mdb overexpression blocks mitotic progression, but
when chromosome separation is allowed by using GAL1-TEV/SCC1-TEV I observed
efficient ME, which occurred almost as rapidly as in the GAL1-TEV/SCC1-TEV strain
lacking GAL1-PDS1-mdb, or the wild-type control (Figure 3.5A).

The

GAL1-PDS1-mdb GAL1-TEV/SCC1-TEV strain exhibited a delay of about 20 minutes
judging from FACS and bud-count.

This delay was consistent with the ME delay in

FEAR network mutants (Stegmeier et al., 2002), but much shorter than the >3-hour
delay caused by GAL1-PDS1-mdb overexpression (Cohen-Fix et al., 1996) (Figure
3.5A). Therefore most of the long delay caused by Esp1 inhibition by Pds1-mdb
overexpression is due to failure of cohesin cleavage.

The temperature-sensitive scc1-73 cohesin allele (Michaelis et al., 1997) allows
sister chromatid separation without Esp1 activity at restrictive temperature (Uhlmann
et al., 1999). I constructed mad2Δ strains that were scc1-73 or SCC1, with or
without GAL1-PDS1-mdb, synchronized cells in G1 with alpha factor, and expressed
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GAL1-PDS1-mdb for one hour before release at 37°C (restrictive temperature for
scc1-73). SCC1 GAL1-PDS1-mdb cells show a lengthy delay before ultimately
undergoing aberrant ME with accumulation of aneuploid cells.

(Eventual

accumulation of aneuploid cells is a consequence of GAL1-PDS1-mdb expression at
37°C, where the G2 block is less stable than at 30°C.

This may be due to lower

expression of GAL1-PDS1-mdb at 37°C) (Figure 3.5B).

In contrast, scc1-73

GAL1-PDS1-mdb cells had indistinguishable ME kinetics compared to scc1-73 cells
lacking GAL1-PDS1-mdb, and similar ME kinetics compared to SCC1 cells lacking
GAL1-PDS1-mdb.

This result confirms that the GAL1-PDS1-mdb block to ME can

be bypassed by cohesin inactivation. Overall, three independent experiments (Figure
3.5A-C) show that the Esp1 requirement for ME can be largely bypassed by
complementing its proteolytic function in Scc1 inactivation. This idea is also
suggested by the similar kinetics of ME in cdc20-blocked cells with GAL1-SIC1-4A
and GAL1-TEV overexpression to the kinetics of ME upon direct release of the cdc20
block (Figure 3.1B).

Stegmeier et al. (2002) carried out a similar experiment to the one in Figure 3.5B.
Instead of inhibiting Esp1 with GAL1-PDS1-mdb, they used the esp1-1
temperature-sensitive allele, and instead of scc1-73, they used the mcd1-1
temperature-sensitive allele (MCD1 is the standard name for the cohesin subunit also
named SCC1). As in my experiment (Figure 3.5A), these strains (with the spindle
checkpoint disabled by MAD1 deletion) were released from an alpha-factor block at
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non-permissive temperature.

They observed a significant reduction in ME delay by

inclusion of mcd1-1 in the esp1-1 background, which is qualitatively similar to my
findings. Distinct from my findings, they observed that the esp1-1 mcd1-1 strain
exhibited a ~45 minutes delay in ME based on timing of mitotic cyclin (Clb2)
degradation compared to the ESP1 mcd1-1 strain, whereas I observed little delay in
ME based on direct examination of cytokinesis comparing the GAL1-PDS1-mdb
strains that were SCC1-wt or scc1-73.

I do not know if the differences in results

between my experiment and the results in Stegmeier et al. (2002) are due to
differences between thermal inactivation of mcd1-1 vs. scc1-73, to the use of esp1-1
vs. GAL1-PDS1-mdb to inhibit Esp1 activity, or to the difference in assay for ME.
Many previous experiments support the efficacy of GAL1-PDS1-mdb in full inhibition
of Esp1 (Cohen-Fix et al., 1996; Queralt et al., 2006; Sullivan and Uhlmann, 2003),
and the results in Figure 3.5B are consistent with the results in Figure 3.5A using
GAL1-TEV rather than scc1/mcd1 mutations to inactivate cohesin.

In a recently

published similar experiment (Visintin et al., 2008), a mad1Δ GAL-PDS1Δdb mcd1-1
strain exhibited a ME delay of 30 minutes or less.

This result is qualitatively

consistent with my observations in Figure 3.5A-B. Variable delays in ME could be
due to different experimental systems or limited resolution.

Thus, I conclude that Esp1 is not required for ME in multiple experimental
conditions, provided the requirement for cohesin cleavage is bypassed, although
absence of Esp1 may cause a <30 min ME delay due to failure of FEAR network
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activation. I propose that provided sufficient Clb-Cdk inactivation, the timing of ME
is largely regulated by the spindle-positioning-checkpoint regulating MEN activation,
as proposed by Bardin et al. (2000). Cohesin cleavage may be a requirement for
efficient activation of the MEN by this mechanism, since anaphase spindle elongation
requires cohesin cleavage, and anaphase efficiently drives one SPB into the bud.

Consistent with the hypothesis that allowing cohesin cleavage bypasses the
Pds1-mdb block by allowing spindle elongation and consequent MEN activation, the
GAL1-PDS1-mdb block to cytokinesis can be effectively bypassed by ectopic
activation of the MEN by deletion of the MEN inhibitor BUB2 in the absence of
chromosome separation (Queralt et al., 2006); I have confirmed this result using HU
block-release instead of cdc20 block-release (Figure 3.6). I explore the connection
between cohesin cleavage, spindle elongation and MEN activation further in the
following sections.
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Figure 3.6

Figure 3.6. GAL-PDS1-mdb bub2∆ (YL0452) or BUB2 (OCF1517.2) strains were
arrested in raffinose medium containing hydroxyurea as described in Materials and
Methods, and released into galactose media lacking hydroxyurea at 30º. DNA flow
cytometry profiles are shown.
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5. Direct block of Scc1 cleavage delays ME in cells with
active Esp1.
The results above indicate that Esp1 contributes little to ME kinetics beyond its
role in cohesin cleavage, leading to the conclusion that Esp1 is not necessary for quite
efficient ME.

A converse question, so far not addressed in my experiments,

concerns the ability of Esp1 to drive ME in cells in which cohesin cleavage and sister
chromatid separation fails – is Esp1 sufficient to drive ME without cohesin cleavage?
This question has been examined previously with the use of the non-cleavable version
of Scc1 expressed from the GAL1 promoter (GAL1-SCC1-RRDD) (Uhlmann et al.,
1999).

In these experiments, blocking sister chromatid separation does not block

Esp1 activation, since endogenous Scc1 is cleaved on schedule even in the presence
of ectopic Scc1-RRDD (Uhlmann et al., 1999). Blocking sister separation with
Scc1-RRDD in the presence of active Esp1 causes a delay in ME estimated between
20 to 60 minutes, depending on the assays for ME and/or on the exact experimental
conditions (Stegmeier et al., 2002; Uhlmann et al., 2000).

I examined this question

using a different assay, by time-lapse microscopy of GAL1-SCC1-RRDD cells
pregrown in raffinose (uninduced) and plated on galactose medium to induce
GAL1-SCC1-RRDD expression.

I observed a variable delay averaging ~1 hr

between the first bud emergence (unaffected by SCC1-RRDD expression) and the
second bud emergence, which requires prior ME, due to SCC1-RRDD expression
(Table 3.1).

I included a Myo1-GFP marker (Bi et al., 1998) to allow measurement

of the time between budding and cytokinesis (determined by Myo1 ring
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disappearance), and observed a delay of ~0.5 hr due to SCC1-RRDD expression.
The difference in delay times between these two assays is interesting and suggests
that even in cells that complete cytokinesis, defects due to failure of cohesin cleavage
cause an additional ~0.5 hr delay in rebudding. Thus my results generally confirm
the previous findings of a significant delay in ME solely due to failure of cohesin
cleavage. An advantage of my assay is that it requires no previous synchronization
of the cells, which avoids potential artifacts, and in addition allows determination of
the variability among individual cells, which can give misleading results in population
studies. Further, the method allows me to observe events preceding ME. Using
cells labeled with GFP-tubulin and blocked in metaphase by Scc1-RRDD, I observed
rapid spindle oscillations, which pushed one SPB back and forth between daughter
and mother cells (Palmer et al., 1989). This oscillatory movement could potentially
activate the MEN by allowing one SPB to contact Lte1 near the bud cortex (Bardin et
al., 2000). This makes a complete assessment of Esp1’s contribution to ME in this
experimental context difficult, since the spindle oscillations might activate the MEN
without any Esp1 activity. This difficulty was circumvented in the next section by
using nocodazole to depolymerize the spindle.
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Table 3.1. Mitotic exit delay caused by noncleavable cohesin. Strain
GAL-SCC1-RRDD TUB1-GFP MYO1-GFP (YL066) was pre-grown in Raffinose
medium, plated on galactose medium, and subjected to time-lapse analysis at 30°C or
37°C as described in materials and methods. Cells that were unbudded at the time of
plating were timed for both the interval from first budding to first cytokinesis
(Myo1-GFP ring contraction and disappearance), and from first budding to the second
budding. For comparison to other published data, we also carried this experiment out
at 37°C; at this temperature, high fluorescent background prevented reliable
assignment of time of cytokinesis, so only bud-to-bud times were assayed for initially
unbudded cells.

Cells were classified according to whether the short spindle ended

in the mother (Mo.) or the daughter cell (Da.). (At 30°C, almost 100% initially
unbudded cells showed defective division, in which the spindle did not elongate but
ended up intact in mother or daughter, in the first cell cycle. At 37°C, 35% initially
unbudded cells elongated the spindle in spite of galactose addition, suggesting
inefficient expression of GAL1-SCC1-RRDD at 37°C. Because we are tracking
individual cells through time, we can exclude such cells from the analysis.) A
MYO1-GFP TUB1-GFP strain lacking GAL1-SCC1-RRDD (BD78-2C) was treated in
parallel as a control, pooling bud-to-bud data for mothers and daughters. All
numbers are in min +/- standard deviation.

The average differences (Δ) from

wild-type are shown, and the P-value for these differences (by t-test). The numbers of
cells (n) examined in each condition are shown in the last column.
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Table 3.1

30°C

WT
SCC1RRDD
37°C
WT
SCC1RRDD

Mo.
Da.

Myo1-GFP
appearance to
disappearance
(min)
75±14
102±20 (Δ 27 min)
112±21 (Δ 37 min)

Mo.
Da.

ND
ND
ND

P-Value Bud to rebud (min)
rel. to
WT

-3

5x10
1x10-4

110±29
169±60 (Δ 59 min)
228±59 (Δ 118
min)
102±8
153±28 (Δ 51 min)
189±99 (Δ 87 min)
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P-Value
rel. to
WT

-2

1x10
1x10-5

-4

1x10
1x10-2

n

18
11
19

12
9
12

In any case, based on my and others’ results with GAL1-SCC1-RRDD, it is clear
that blocking cohesin cleavage while allowing Esp1 activity causes a substantial delay
in ME. In turn, this suggests that the kinetics of ME in the wild-type cell cycle are
driven by cohesin cleavage, since the time from cohesin cleavage to ME in wild-type
cells is only ~15-20 minutes (Stegmeier et al., 2002), shorter than my estimate of the
time required for ME in the presence of active Esp1, but without cohesin cleavage.
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6. Mitotic exit promoted by Esp1 over-expression depends on
spindle elongation and MEN activation

Esp1 over-expression, but not TEV-induced spindle elongation, was shown to
drive ME in cdc20-depleted cells, without a requirement for Esp1 proteolytic activity
(Queralt et al., 2006; Sullivan and Uhlmann, 2003).

I have confirmed the finding

that Esp1 overexpression drives ME in cdc20-depleted cells, even using the attenuated
GALS promoter driving ESP1 instead of 6 copies of GAL1-ESP1 (Queralt et al., 2006;
Sullivan and Uhlmann, 2003). Expression of GALS-ESP1 still constitutes an
approximately 30-fold overexpression based on comparison of accumulation of
Myc-tagged Esp1 from the GALS vs. the endogenous promoter (data not shown).

It

is also an effective overexpressor based on rescue of PDS1-mdb lethality; see above.
For most purposes I prefer the GALS-ESP1 construct because it allows viability,
unlike 6xGAL1-ESP1.

I found efficient induction of ME by GALS-ESP1, with all

markers of ME (cytokinesis, rebudding, Clb2 degradation and DNA replication in the
next cell cycle) occurring promptly upon GALS-ESP1 induction (Figure 3.7A).

This

Esp1-induced ME was much more efficient than that described previously (Sullivan
and Uhlmann, 2003).

This is likely a consequence of performing the experiment a.

30° rather than at 23°. 6X GAL1-ESP1 also drove much more efficient ME at 30° than
at 23° (Figure 3.8D).

Thus, I confirm the previous finding (Sullivan and Uhlmann, 2003) that
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overexpressed Esp1 drives ME in cdc20-blocked cells.

To further analyze this

response, I tested if overexpressed Esp1 could drive ME in the presence of
nocodazole to depolymerize the spindle. Inclusion of nocodazole blocked ME in all
aspects I have tested for at least 3 hours (Figure 3.7A). Thus, overexpressed Esp1
may not be intrinsically sufficient to drive ME in cdc20-depleted cells. This ability
of Esp1 may rely on spindle elongation consequent to cohesin cleavage by the
proteolytic function of Esp1.

In these experiments I primarily used strains

containing a CDC14 allele endogenously tagged with YFP, in order to follow Cdc14
trafficking in later analysis (see below). This CDC14-YFP was previously shown to
fully complement, and to be competent for FEAR- and MEN-induced nucleolar exit
(Pereira et al., 2002). I also have confirmed key results in isogenic strains with
untagged CDC14 (Figure 3.8A). The involvement of the spindle integrity
checkpoint surveillance system in this result seemed unlikely since the experiment
was performed in a cdc20-depleted background, removing the target of the checkpoint
(Hwang et al., 1998; Kim et al., 1998).

In addition, I have performed the same

experiment in the absence of the essential spindle checkpoint component Mad2, with
identical results (Figure 3.8B).

Spindle elongation could promote ME by driving the daughter spindle pole into
contact with the bud cortex, activating the MEN (Bardin et al., 2000; Stegmeier and
Amon, 2004; Yeh et al., 1995). To test this, I inhibited MEN activation with a
temperature-sensitive cdc15-2 mutation (Cdc15 is an essential MEN component).
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cdc15-2 completely inhibits GALS-ESP1-induced ME at 35.5°C (Figure 3.7B).

Thus, promotion of ME by Esp1 overexpression in cdc20-blocked cells requires
both an intact and a functional MEN, even if Clb-Cdk inhibition is provided
ectopically. I hypothesize that the requirement for spindle integrity for Esp1
promotion of ME arises because Esp1-mediated cohesin cleavage allows spindle
elongation, promoting effective contact between the daughter SPB and the bud cortex
and thereby promoting MEN activation (Bardin et al., 2000; Yeh et al., 1995).
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Figure 3.7. Mitotic exit promoted by Esp1 overexpression depends on an intact
spindle and MEN activation.

A. A MET3-CDC20 GALS-ESP1 strain (YL1361)

was arrested by Cdc20 depletion, as in Fig. 3.1.

Esp1 was expressed from the GALS

promoter at time zero by adding galactose (G) in the absence or presence of
nocodazole + benomyl (NOC) (methionine was kept in the medium throughout to
maintain Cdc20 depletion).

DNA flow cytometry and protein samples were taken.

Microscopic examination allowed quantification of the following phenotypes: Black:
large budded mononucleate cell. Red: large budded binucleate cell. Green: rebudded
cell without cytokinesis. Blue: unbudded or small budded cell. (lower right).
Squares: without nocodazole; circles: with nocodazole. Western blotting was used to
assess the level of Clb2 (amido-black staining of the gels showed equal loading of all
lanes [data not shown]). B. MET3-CDC20 GALS-ESP1 strains, either CDC15
(YL1361) or cdc15-2 (YL1362) were treated and analyzed as in (A), except that the
cultures were maintained at 35.5°C to inactivate cdc15-2.

Squares: CDC15-wt;

circles: cdc15-2. Nonspecific band “*” was used as a loading control.
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Figure 3.7
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Deletion of CLB5 may lower the threshold of Cdc14 activity required for
triggering ME, since it rescues viability of cdc20 pds1 cells (Shirayama et al., 1999;
Sullivan and Uhlmann, 2003).

Thus, CLB5 deletion might sensitize detection of an

ability of Esp1 to drive ME, even without an intact spindle. However, the result in
Figure 3.7A is robust to deletion of CLB5, implying that spindle function is strongly
required for GALS-ESP1-induced ME (Figure 3.8C).

As shown in Figure 3.1, partial ME is obtainable with complete Clb-Cdk
inhibition driven by GAL1-SIC1-4A, and ME becomes more efficient with concurrent
expression of GAL1-TEV to provide cohesin cleavage.

I examined the ability of

GALS-ESP1 to substitute for GAL1-TEV in this protocol, by a factorial experiment
combining the presence or absence of GALS-ESP1 and of nocodazole, all in the
presence of GAL-SIC1-4A. GALS-ESP1 promoted strong ME only in the absence of
nocodazole.

In the presence of nocodazole, I observed the partial ME attributable to

GAL1-SIC1-4A (Figure 3.1B), independent of the presence or absence of GALS-ESP1
(Figure 3.9).

Thus, even with complete Clb-Cdk inhibition, I detect no

ME-promoting activity of Esp1 in the presence of nocodazole.
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Figure 3.8. A. MET-CDC20 GALS-ESP1 (YL121) strain was arrested in Raffinose
plus methionine, then experiments were performed as described in Fig. 3.7A. Results
of DNA flow cytometry analysis and Clb2 western blot are shown. Even loading of
samples were shown by amido-black staining (data not shown). B. A MET-CDC20
mad2∆ GALS-ESP1 (YL169) strain was arrested by incubation in
raffinose+methionine medium to deplete Cdc20. Galactose or
Galactose+nocodazole+benomyl was added at time zero, keeping methionine present
to maintain the cdc20 block. DNA flow cytometry and Clb2 western blot were
performed as described in Materials and Methods. Pgk1 was employed as a loading
control. C. Nocodazole inhibited ME caused by Esp1 overexpression in the absence
of Clb5. MET-CDC20 clb5∆ GALS-ESP1 (YL134) was arrested by incubation in
raffinose+methionine medium to deplete Cdc20. Galactose or Galactose + nocodazole
+ benomyl was added at time zero, keeping methionine present to maintain the cdc20block. DNA flow cytometry and Western blot analysis were done as described in
Materials and Methods. Samples were evenly loaded as shown by Amido-Black
staining of the membrane after protein transfer (data not shown). The lower right
panel shows the fraction of large budded cells. D. Esp1 overexpression induced more
efficient ME at 30˚. MET-CDC20 6xGAL-ESP1 (strain 393, from F. Uhlmann) was
arrested by incubation in raffinose+methionine medium to deplete Cdc20.

Galactose

was added at time zero, keeping methionine present to maintain the cdc20- block, at
either 23˚ or 30˚. Results of DNA flow cytometry analysis are shown.
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Figure 3.8
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Figure 3.9

Figure 3.9. MET-CDC20 GAL-SIC1-4A strains, with (YL1721) or without (YL1722)
GALS-ESP1 were arrested by incubation in raffinose+methionine medium to deplete
Cdc20.

Galactose or Galactose+nocodazole+benomyl was added at time zero,

keeping methionine present to maintain the cdc20 block. This experiment was
carried out at 23º. Upper panels show the fraction of large budded cells (without
rebudding) (left) and the fraction of rebudded cells, i.e. large-budded cells with extra
small buds attached (right). Note that these graphs exclude cells produced by normal
mitotic exit, which are not large-budded and are either unbudded, or contain a small
bud. Lower panels show the results of DNA flow cytometry analysis.
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7. Quantitative measurement of Esp1-induced Cdc14 release
and activity

The ability of overexpressed Esp1 to promote ME was attributed to its ability to
promote MEN-independent Cdc14 release from the nucleolus (Sullivan and Uhlmann,
2003).

It is well established that the activity of Cdc14 is regulated by its localization

in the nucleolus, where it is stably bound to its inhibitor Net1 and also sequestered
from many potential dephosphorylation targets.

The MEN is known to drive

efficient release of Cdc14 from the nucleolus. (Shou et al., 1999; Visintin et al., 1999).
It is important to note that the release status of Cdc14 is not all-or-none. The terms
“partial release” and “full release” have been introduced to qualitatively describe
Cdc14 localization (Stegmeier et al., 2002).

Here, I use 2-color imaging with

Cdc14-YFP and Net1-CFP (Pereira et al., 2002) and define a parameter “r” for any
individual cell based on quantitative fluorescence microscopy.
r=

the mean intensity of 5% brightest YFP pixels - the mean intensity of 5% dimmest YFP pixels
the mean intensity of 5% brightest CFP pixels - the mean intensity of 5% dimmest CFP pixels

This value will be high when Cdc14-YFP and Net1-CFP are colocalized, and low
when Cdc14-YFP is significantly more dispersed than Net1-CFP (which is thought to
remain nucleolar throughout the cell cycle).

Thus, a lower r value should indicate

higher Cdc14 release from Net1, and consequently increased Cdc14 activity.

To

establish the validity of this approach, I measured r throughout a cdc20 block-release
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experiment.

At 30 minutes post release, cells with low r values appear exclusively in

the anaphase subpopulation.

10 minutes later, Cdc14-YFP is resequestered into the

nucleolus as the low-r fraction diminishes (Figure 3.10A).

Thus, the r statistic

clearly reflects the known dynamic localization behavior of Cdc14.

(It is notable in

these images that I essentially never observe complete absence of Cdc14 from the
nucleolus; corresponding to this, the r value is never below ~0.3 in this experiment,
where a value of 0 would correspond to uniform spreading of Cdc14 through the cell.)

67

Figure 3.10. Quantitative measurement of Cdc14 release.

A. A MET3-CDC20

CDC14-YFP NET1-CFP strain (YL1452) was arrested in metaphase by incubation in
+Met medium, and released at time zero by removal of Met. The “r” value
(characterizing the degree of cellular dispersion of Cdc14 relative to Net1) for cells at
various time-points was determined as described in Materials and Methods. Yellow
curve: r value distribution in anaphase subpopulation. Green curve: r value
distribution in unbudded/small-budded/rebudded cells. Red curve: r distribution in
metaphase subpopulation.

X axis is the r value; Y axis is frequency. The red, green

and yellow distributions sum to the total histogram of r values (bars). Arrowhead on
the picture highlights the bud-neck localization of Cdc14-YFP at ME. White numbers
indicate r values for specific representative cells. Scale bar: 10 microns. In this and all
the following experiments involving r value measurement, at least 50 cells were used
to generate the distribution for each category at each time point. B. A MET3-CDC20
6xGAL1-ESP1 strain (YL1451) was arrested in metaphase by incubation in +Met
medium. Galactose (G) or Raffinose (R) were added at time zero in the presence
(+NOC) or absence (-NOC) of nocodazole + benomyl (methionine was kept in the
medium throughout to maintain Cdc20 depletion).
were determined as in A.
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At the indicated times, r values

Figure 3.10
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I then examined the ability of overexpressed Esp1 to drive Cdc14 release from
the nucleolus in cdc20-blocked cells, with or without spindle depolymerization
induced by nocodazole. In these experiments, I used 6xGAL1-ESP1 (Sullivan and
Uhlmann, 2003) instead of GALS-ESP1 because the higher overexpression produced a
stronger and more synchronous phenotype. (Qualitatively similar results were also
obtained with GALS-ESP1).

I observe Cdc14 release (low r value cells) in

Esp1-overexpressing cells undergoing spindle elongation and anaphase; strikingly,
addition of nocodazole blocked Cdc14 release measured by this assay (Figure 3.10B)

I have quantified Cdc14 release in CDC15 or cdc15-2 cells, both MET3-CDC20,
released from a cdc20 block at 37° to inactivate cdc15-2. Upon release, r shifted
strongly and transiently to a low value 20 minutes after release in the CDC15 control.
In contrast, I observed only a slight decrease in r in the cdc15-2 cells; this decrease
was maximal at 20 minutes after release. Some Cdc14-YFP speckles outside the
nucleolus are observed in cdc15-2 cells, but are largely absent in the CDC15-wt
control (Figure 3.11); I do not know what these signify.

Any MEN-independent

Cdc14 release is apparently described by the small but reproducible decrease in r at 20
minutes after release, and the occurrence of the Cdc14-YFP speckles. Thus, Cdc14
release driven by the MEN is qualitatively and quantitatively stronger in my
experiments than MEN-independent release.
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Figure 3.11.

(Left). MET-CDC20 CDC14-YFP NET1-CFP strains, either CDC15

(YL1361) or cdc15-2 (YL1362) were arrested in metaphase by incubation in
methionine-containing medium to deplete Cdc20, then released into methionine-free
media at 37° to inactivate cdc15-2. Samples were taken every 10 minutes, the cells
were briefly fixed and quantitative fluorescence microscopy (see Materials and
Methods) was used to calculate the r value for individual cells. The colored lines
represent histograms of cells at each r value, with the morphology indicated in the
cartoons below, based on Net1-CFP staining. The bars represent the complete
histogram of r values (sum of the colored lines). Right: Sample pictures at indicated
time points. Scale bar:10 μm. Images are linearly contrast-enhanced for better
visualization.
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Figure 3.11
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I conclude that separase Esp1 promotes ME in cdc20-blocked cells primarily via
cohesin cleavage and consequent spindle elongation, rather than by a
cohesin-cleavage-independent function of Esp1.

The experiments described above

implicate MEN activation as the proximal target of spindle elongation, resulting in
effective Cdc14 release to drive ME.

A high level of CDK activity was shown to induce Cdc15 phosphorylation and
lower Dbf2 kinase activity, and these reactions could have the potential to impair
Cdc14 release (Jaspersen and Morgan, 2000; Menssen et al., 2001; Stegmeier et al.,
2002). I were concerned, therefore, that my experimental manipulation of blocking
Cdk inactivation was not truly independent of promotion or prevention of Cdc14
release.

To investigate this, I quantified the release kinetics of Cdc14 in the presence

of undegradable Clb2 (Clb2-kd, lacking the KEN boxes and destruction box.
CLB2-kd at its endogenous locus is lethal, but can be rescued by Sic1 overexpression
from the GAL1 promoter (Wasch and Cross, 2002); GAL1-SIC1 turnoff in this strain
results in a block to ME (Wasch and Cross, 2002)).

I synchronized a GAL1-SIC1

CLB2-kd CDC14-YFP NET1-CFP MYO1-mCherry strain in G1 with alpha factor, and
released into glucose to shut off Sic1 expression, or into galactose as a control.
Cell-cycle progression was monitored by budding, Myo1-mCherry to mark the bud
neck and cytokinesis (Bi et al., 1998) and the separation of the Net1-CFP signal
across the bud neck was monitored to assay anaphase.

Clb2kd cells arrest in

telophase as described (Wasch and Cross, 2002), but Cdc14 release was very efficient,
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essentially coincident with anaphase and then persisting for about 30 minutes (Figure
3.12A).

This result essentially confirms a previous finding of Cdc14 release in the

presence of undegradable Clb2 (Stegmeier et al., 2002), obtained using CLB2-db
overexpression from the GAL1 promoter.
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Figure 3.12

Figure 3.12. Cdc14 release occurs despite persistent endogenous Clb-Cdk
activity. A: Strain CLB2,kd GAL1-SIC1 CDC14-YFP NET1-CFP MYO1-mCherry
(ALG611) was arrested in alpha factor in galactose media, then released into either
glucose to turn off GAL1-SIC1 (Glu) or galactose media (Gal) to keep GAL1-SIC1 on.
Cdc14 localization was quantified as in Fig. 3.10.

DNA flow cytometry, Clb2

western blot and r value test were performed as described in Materials and Methods.
The inset cartoon shows the cell morphology of each category. B. MET3-CDC20
cdh1Δ GALS-ESP1 (YL165) cells were first arrested in metaphase by incubation in
raffinose plus methionine medium, then galactose plus methionine was added to
induce Esp1 overexpression at time zero. DNA flow cytometry, Clb2 western blot and
r value test were performed as described in Materials and Methods.
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In a different experimental approach to the same question, I assayed GALS-ESP1
induction of ME in cdc20-blocked cells (as in Figure 3.7A), in the absence of CDH1.
These cells lack any factor to activate the APC for Clb degradation, since at least one
of either Cdc20 or Cdh1 is required for Clb degradation (Wasch and Cross, 2002).
Unlike CDH1 controls (Figure 3.7A), the cdh1 cells maintained a stable telophase
block without any evidence of ME in this protocol, for up to four hours (when some
degree of rebudding occurs).

Despite this stable block, very efficient Cdc14 release

was observed throughout this period (Figure 3.12B).

These results show that stabilized Clb cyclins cannot block Cdc14 release when
expressed at endogenous levels.

Therefore spindle elongation is likely to be the

primary mechanism driving full Cdc14 release, rather than a separase-dependent but
cohesin cleavage-independent mechanism, such as a Cdc14-Cdc15 positive feedback
triggered by Esp1 (Queralt et al., 2006).

The experiments in Figures 3.7 and 3.12 allow me to propose a model for
induction of ME by ESP1 overexpression in cdc20-blocked cells: the overexpressed
Esp1 cleaves cohesin and allows spindle elongation, prompting MEN activation when
the daughter spindle pole reaches the bud cortex (Bardin et al., 2000; Yeh et al., 1995).
MEN activation promotes Cdc14 release, which can activate Cdh1 by
dephosphorylation (Zachariae et al., 1998), leading to Clb degradation. My results
with nocodazole, cdc15-2, and cdh1 suggest that all of these steps are required for
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overexpressed Esp1 to induce effective ME.
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8. Mitotic exit network controls Cdc14 nuclear export

Net1 sequestration in the nucleolus is the only characterized mechanism for
regulation of Cdc14 activity; hence net1 deletion would be expected to completely
relieve any MEN-dependent regulation of Cdc14.

However, I were surprised to find

that in net1Δ cells, Cdc14-YFP localization is still cell-cycle regulated, being
concentrated in the nucleus for most of the cell cycle, but spread throughout the cell
transiently at ME (Figure 3.13B).
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Figure 3.13. Mitotic Exit Network controls Cdc14 nuclear export. A. WT and
net1Δ cells containing CDC14-YFP (YL1701) were briefly fixed and stained with
DAPI to label DNA (top); net1 CDC14-YFP strains containing NOP1-dsRed (YL1702)
or dsRed-NLS (YL174) were examined separately. B. Selected frames of a
time-lapse movie (Bean et al., 2006) with indicated strain genotypes. In net1Δ
CDC14-YFP (YL1701) cells, Cdc14-YFP was transiently excluded from the nucleus
approximately at the time of ME. This transient nuclear exclusion was not observed in
net1Δ CDC14-YFP cdc15-2 (YL161) cells at 37°C. C. The percentage of cell cycles,
tracked using fluorescent time-lapse microscopy, in the course of which Cdc14-YFP
release from nucleus was observed. 50 cell cycles were examined in each condition.
D. Quantification of Cdc14 release from nucleus in a net1Δ background. The
coefficient of variation (CV) of Cdc14-YFP signal inside a single cell, computed from
fluorescent time-lapse microscopy data, is the standard deviation of YFP pixel
intensity across the cell, divided by the mean intensity; this number will be high in
cells with Cdc14-YFP concentrated in specific regions, and low when Cdc14-YFP is
dispersed through the cell.

Four examples of CDC15-wt (blue) and cdc15-2 (red)

cells, both at 37°, are shown. Curves are aligned by nuclear division as judged by
initial stretching of the Cdc14-YFP signal across the bud neck, at t=0. Color bars
indicate rebudding in the next G1.
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Figure 3.13
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To examine the possibility that this result is due to residual binding of Cdc14 to
other nucleolar components, I examined colocalization of Cdc14-YFP with DNA,
with the nucleolar marker Nop1-dsRed (Gadal et al., 2001), and with a general marker
of nuclear volume, dsRed-NLS (Rodrigues et al., 2001).

In NET1 cells, Cdc14 is in

a typical crescent-shaped nucleolar distribution flanking the bulk of nuclear DNA,
while in net1 cells, Cdc14-YFP staining is enlarged to contain the DNA signal. In
net1 cells, Cdc14-YFP is localized much more broadly than the Nop1-DsRed
nucleolar marker, but is coincident with the dsRed-NLS marker for the nuclear
interior.

Thus, in net1 cells, Cdc14 is not retained in the nucleolus but is

nevertheless restricted to the nucleus (Figure 3.13A), through most of the cell cycle.

I used time-lapse fluorescence microscopy to study whether the MEN is
responsible for Cdc14 nuclear export in the absence of Net1. When the MEN is
inactivated at restrictive temperature in a cdc15-2 net1Δ strain, Cdc14-YFP remains
concentrated in the nucleus throughout the cell cycle, in contrast to CDC15 net1Δ
cells with an intact MEN (Figure 3.13B,C).

(Note that the net1 deletion bypasses the

cdc15 block to telophase exit, as expected (Shou et al., 1999)).

The Cdc14 nuclear

export phenotype can be quantified using time-lapse microscopy to calculate the
dispersion of Cdc14-YFP signal inside individual cells. A decrease of CV
(Coefficient of Variation) corresponds to Cdc14 nuclear export (because Cdc14 is no
longer concentrated, therefore the signal across the cell is less variable). A drop in the
CV for Cdc14-YFP is clearly detected in CDC15 cells at low and high temperatures,
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but absent in cdc15-2 cells specifically at 37° (Figure 3.13D). CDK activity by itself
is unlikely to control Cdc14 export, since the timing of Clb2 degradation in cdc15-2
net1Δ is almost identical to CDC15 net1Δ (Figure 3.14) as expected (Shou et al.,
1999).

Cdc14 nuclear export is probably not directly driven by Esp1 activity,

because the timing of this Cdc14 nuclear export correlates with ME rather than
anaphase (which is directly promoted by Esp1 activity), and because Cdc14 nuclear
export is impaired in net1Δ cdc15-2 cells where Esp1 activity is presumably normal.
Consistent with my observation, a nuclear export sequence in yeast Cdc14 has been
reported. Mutations of that sequence cause Cdc14 to fail to localize to the bud neck
during mitotic exit (Bembenek et al., 2005). Functions of the Cdc14 nuclear export
signal may be tied to MEN activation.

These observations implicate the MEN in a previously unsuspected aspect of
Cdc14 activation: its release from the nucleus and dispersal throughout the cell.

This

activity may contribute to the ability of the MEN, but not FEAR- or Esp1-induced
Cdc14 release, to promote complete mitotic exit. A recent publication showing that
the MEN component Dbf2 is involved in Cdc14 nuclear export, independent of its
role in promoting Cdc14 nucleolar release, confirmed my observation (Mohl et al.,
2009).
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Figure 3.14

Figure 3.14. net1∆ bypasses the MEN requirement for Clb2 degradation but not
for cytokinesis. net1∆ cdc15-2 (YL1541) or net1∆ CDC15 (YL1542) strains were
arrested in alpha factor at 27˚. At time zero, the cultures were released by removal of
alpha factor. Release was at 37˚ to inactivate cdc15-2. Alpha factor was added back
at 100 minutes to prevent cells from entering the next cell cycle. Cytokinesis was
assessed by the occurrence of a 1C DNA peak in DNA flow cytometry profile.

Clb2

degradation was assessed by Western blot and quantified relative to a control Western
blot of Pgk1.
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9. Clb-Cdk activity may cooperate with Cdh1 to prevent
Cdc14 from returning into the nucleolus

I demonstrated that Esp1 overexpression induced long-term release (~3 hours) of
Cdc14-YFP in cdc20- cdh1- cells (Figure 3.12B).

Since Cdc14 release normally

only lasts for 15~20 minutes, it is interesting to know which factor prevents Cdc14
from returning into nucleolus in this condition.

In cdc20- CDH1+ cells, Esp1 overexpression induces Cdc14 release of normal
duration (~20 minutes), which leads to mitotic cyclin-Cdk inactivation and ME events
(Figure 3.10B).

Addition of NOC to the medium prevents induction of Cdc14

release and cyclin-Cdk degradation by Esp1 overexpression (Figure 3.7A, 3.10B).
Therefore, the spindle could serve as a signaling center to sustain Cdc14 release status
until its disassembly at ME.

Alternatively, Cdc14 release could also be sustained by

Clb-Cdk activity. To test those hypothesis, MET-CDC20 cdh1 cells were blocked by
depleting Cdc20, and Esp1 was overexpressed from GALS promoter at t=0.

After 90

minutes when >95% cells had went through anaphase and released Cdc14, the culture
was split into two.

NOC was added into one culture to disassemble spindle, and

Cdc20 was re-induced in the other culture to degrade mitotic cyclins. ME events
and Cdc14 release were monitored during the time-course.

In cdc20- cdh1- cells,

NOC did not cause also any appreciable changes to either Cdc14 release or rebudding
kinetics compared with NOC-free culture (Figure 3.15A, Figure 3.12B). In the
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culture where Cdc20 was re-induced at 90 minutes, I initially observed a further
release of Cdc14-YFP at 115 minutes reflected as a lower-shift of the r-value
distribution.

Then, Cdc14 rapidly returned into nucleolus (Figure 3.15A). Since

Cdc20 re-induction causes mitotic cyclin inactivation, mitotic cyclin-Cdk activity may
prevent Cdc14 from returning into nucleolus in cdc20- cdh1- cells.

In this

experiment, I observed that Cdc14 release by Esp1 overexpression in cdc20- cdh1cells was quantitatively incomplete.

I compared the pictures from maximum

Cdc14-release time point in CDH1+ and cdh1- cells, induced by Esp1 overexpression.
Cdc14-YFP localization appeared to be more nuclear concentrated in cdh1- cells
(Figure 3.15B). (Note: even in control experiments, I never observe complete Cdc14
release from the nucleolus; there is usually a weak Cdc14-YFP signal in the nucleolus
even if Cdc14 release already reached its maximum by quantification.) cdc20- pds1Δ
cells can achieve a similar telophase arrest with high mitotic cyclins and released
Cdc14 (Shirayama et al., 1999) without Esp1 overexpression. In those cells,
Cdc14-YFP localization also appeared to be nuclear concentrated (Figure 3.15B).
Therefore, mitotic cyclin-Cdk activity could retain Cdc14 in the nucleus and prevent
Cdc14 from returning into nucleolus, which potentially explains why the FEAR
network-induced Cdc14 tends to regulate events in the nucleus (such rDNA
segregation, spindle elongation), but does not induce cytokinesis.

The relationship

between this nuclear concentration of Cdc14, induced by mitotic cyclin-Cdk, and the
MEN-induced nuclear exit of Cdc14 (even after nucleolar exit) documented in the
preceding section, remains to be clarified.
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Figure 3.15. A. Strain MET-CDC20 cdh1∆ GALS-ESP1 was grown in raffinose
medium and blocked with cdc20- by adding methionine to the culture. 90 minutes
after GALS-ESP1 induction at t=0, the culture was split into two. NOC was added to
one culture (left), and Cdc20 was reinduced in the other culture by washing away
methionine (right).

Samples were taken at indicated time points, and Cdc14

localization was analyzed as described in Materials and Methods. Bar plot: r value
distribution for the entire population. Red/green/blue/purple curve: r value
distribution for metaphase/anaphase/rebudded/small-budded subpopulations.

B.

MET-CDC20, MET-CDC20 cdh1∆ GALS-ESP1, and cdc20::GALL-CDC20 pds1∆
strains, containing CDC14-YFP NET1-CFP were blocked with cdc20-.
MET-CDC20 cells were released into cell cycle progression by washing away
methionine, and the picture showing Cdc14 release was taken at 30 minutes after
release. Galactose was adding to MET-CDC20 cdh1∆ GALS-ESP1 cell culture to
overexpress Esp1, and the picture was taken 2 hours later. The cdc20::GALL-CDC20
pds1∆ picture was taken 4 hours after adding glucose in the culture to turn off the
expression of Cdc20.
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Figure 3.15
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10. Spindle checkpoint inactivation by FEAR-induced Cdc14
release

I showed in Figure 3.7A that Esp1 ovexpression did not induce ME or Clb2
degradation in cdc20- cells with NOC added.

However, it is known that Esp1

overexpression induces efficient Clb2 and Pds1 degradation in NOC arrested cells
(with Cdc20p present, but presumably inhibited by the spindle
checkpoint)(Tinker-Kulberg and Morgan, 1999), suggesting that Esp1 overexpression
can inactivate spindle checkpoint in NOC, likely through releasing Cdc14.

If FEAR-released Cdc14 can activate Cdc20 to degrade Pds1 and release
inhibition of Esp1, Esp1 will cause more Cdc14 release by activating FEAR network,
potentially forming a positive feedback loop to accelerate cell cycle recovery from
spindle checkpoint arrest.

I tested this idea by comparing Pds1p degradation kinetics

in slk19, cdc14-1, esp1-1, and esp1-1 ESP1C1531A cells following release from NOC
arrest.

Consistently, I found that Pds1p degradation was delayed in both slk19Δ and

cdc14-1 cells by 10~15 minutes, compared with WT cells (Figure 3.16).

But

interestingly, Pds1 degradation was not affect by the non-proteolytic function of Esp1.
In a recent publication, Cdc14 is shown involved in a positive feedback loop with
Cdc20 to achieve a coherent metaphase-anaphase transition(Holt et al., 2008); the
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involvement of Esp1 (with or without its proteolytic activity) was not addressed in
this publication, but the work is still consistent with the idea proposed above that
Cdc14 accelerates escape from checkpoint arrest.
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Figure 3.16

Figure 3.16. slk19∆, esp1-1, esp1-1 ESP1C1531A, cdc14-1 and wild-type cultures
were arrested in glucose medium + NOC +BEN at 25℃ as described in Materials and
Methods. Then, temperature was shifted to 37℃ to inhibit temperature-sensitive
alleles, and the cultures were released into cell cycle by washing away NOC+BEN,
still at 37℃. Protein samples were taken at indicated time points to analyze
Pds1-18Myc levels using western blot with anti-Myc antibody. Pgk1 was the loading
control.
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11. Discussion

In budding yeast, Cdc14 is absolutely required for ME, and much evidence
indicates that Cdc14 can not promote ME until it is released from its nucleolar anchor
Net1.

My results in this chapter show that efficient ME requires CDK inactivation

and spindle elongation driving MEN activation, but Esp1 is not required beyond the
need for cohesin cleavage.

Furthermore, I devised a quantitative method to measure

Cdc14 activity, which revealed that Cdc14 release driven by Esp1 overexpression
depends on spindle elongation and MEN activation.

My conclusion is consistent

with previous findings that the FEAR network is dispensable for the cell cycle, while
MEN activation is essential for effective release of Cdc14 from Net1 (Hofken and
Schiebel, 2002; Shou et al., 1999; Stegmeier et al., 2002; Visintin et al., 1999).
Interestingly, separase is also not required for ME in mammalian cells or fission yeast
(Hirano et al., 1986; Wirth et al., 2006)

An absolute requirement for Esp1 in ME was supported by the finding that Esp1
overexpression, rather than TEV-protease induced spindle elongation, triggered ME
(Sullivan and Uhlmann, 2003).

These results, which I have confirmed (data not

shown), were obtained in a cdc20-deficient background, and I interpret the apparent
Esp1 requirement to be due to high Clb-Cdk activity levels because of Cdc20
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depletion. In my experiments where anaphase is promoted by TEV protease or by
mutational inactivation of cohesin, ME can occur in the absence of Esp1 activity if
Cdc20p is kept active (allowing mitotic cyclin degradation), or if Clb-Cdk activity is
inhibited by GAL1-SIC1-4A. In the presence of high Clb-Cdk levels, TEV protease
may promote transient spindle elongation which only partially activates MEN,
causing failure to exit from mitosis in cdc20 arrest (Higuchi and Uhlmann, 2005).

The requirement for inactivation of Clb-Cdk1 activity before ME places
APC-Cdc20 in a uniquely important position in the ME control system. Mitotic
cyclin degradation in budding yeast is biphasic (Yeong et al., 2000).

APC-Cdc20

degrades Clb5,6 and partially degrades Clb1,2 at the metaphase to anaphase transition,
which may lower the overall Cdk activity level sufficiently to allow ME, once the
MEN is triggered by spindle elongation.

Consistently, deleting CLB5 to lower

Clb-Cdk activity can restore viability to cdc20Δ pds1Δ strains (Shirayama et al., 1999).
Thus, the stable arrest observed in cdc20 cells cannot be overcome simply by
allowing Esp1 to escape from Pds1 inhibition (either by pds1 deletion or by ESP1
overexpression); Cdk inactivation is independently required, and is provided in the
first phase of Clb degradation in the wild-type system by Cdc20.

Cdc20 is even

required to recover from cdc15-2 arrest (Yeong et al., 2000). A likely explanation is
that depletion of Cdc20 during a cdc15-2 arrest increases the Clb cyclin level, making
the cell unable to recover from telophase arrest after being shifted to permissive
temperature.

The mechanism by which Clb-Cdk inhibits ME is unknown. High
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Clb-Cdk may block cytokinesis and rebudding directly (Eluere et al., 2007;
Padmashree and Surana, 2001).

These results thus suggest that Esp1 is not sufficient

to drive ME, even when overexpressed.

The esp1-2td allele is thought to completely remove separase activity (Queralt et
al., 2006). In my hands this allele only causes a 2 hour delay in ME (data not
shown), confirming recent results (Visintin et al., 2008).

These results support my

conclusions derived using Pds1 as an Esp1 inhibitor (see above) in suggesting that
Esp1 is not necessary for ME.

Its absence does clearly delay ME very significantly,

but I suggest that most or all of this delay is due to failure of cohesin cleavage, which
prevents spindle elongation, greatly delaying MEN activation and Cdc14 release.

It

is clear from much work that Cdc14 release is essential for ME.

Cdc14 release is thought to be biphasic: Esp1 induces the FEAR network,
promoting the first wave of Cdc14 release in early anaphase. ME is delayed until the
second wave of Cdc14 release, promoted by the MEN; the reason for this delay is
unknown.

My quantification of Cdc14 release suggest that Esp1 and the FEAR

pathway, in the absence of spindle elongation or MEN activity, do not promote a
quantitatively or qualitatively sufficient degree of Cdc14 release to trigger ME.
Esp1-induced Cdc14 release has been reported to fulfill ME-independent functions,
such as stabilizing the anaphase spindle (Jensen et al., 2001).

The functional

diversification of Cdc14 at early and late anaphase might in part be due to the ability
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of MEN to control Cdc14 nuclear export, independent of its restriction to the
nucleolus; nuclear export could allow access of Cdc14 phosphatase to additional
substrates. Consistently, in net1Δ cells, the bud-neck localization of Cdc14-YFP only
appears at ME when the MEN is activated and Cdc14 release from the nucleus is
promoted.

I do not observe bud-neck localization of Cdc14 upon ESP1

over-expression, if spindle elongation is inhibited by nocodazole (Figure 3.10B).
Intact microtubules are not likely to be intrinsically required for ME or Cdc14 release,
since in a mad2 bub2 double mutant, lacking all known spindle surveillance pathways,
microtubule depolymerization with nocodazole has no effect on the kinetics of Clb2
degradation, rebudding and DNA replication in the subsequent cell cycle (Alexandru
et al., 1999), strongly suggesting that Cdc14 phosphatase was properly released and
activated at ME in this context. I cannot completely exclude the possibility that the
FEAR network could require an intact spindle to function for reasons unrelated to
ultimate spindle elongation.

However, my conclusions are consistent with the

finding that both Cdc14 release and ME (assessed by spindle disassembly) in the
dyn1Δ mutant coincide with SPB moving into the bud, rather than spindle elongation
per se (i.e. separase activation) which frequently happens within the mother cell body
in this mutant (Bardin et al., 2000). In these cells, the spindle is intact, but Esp1 still
appears unable to promote ME on its own.

Esp1-induced Cdc14 release was previously reported to occur in nocodazole
(Visintin et al., 2003). I observe a spreading of the Cdc14-YFP signal in
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cdc20-depleted cells after long-term induction of ESP1–overexpressing cells in
nocodazole, but an essentially identical spreading of Net1-CFP was also observed,
which colocalized with Cdc14-YFP, accounting for the maintenance of a high r value
(Figure 3.10B).

I do not know whether this spreading is due to the release of Net1 as

well as Cdc14 from the nucleolus, or to a general disruption of nucleolar structure.
The tight colocalization suggests that Net1 has the potential to bind and inactivate
Cdc14 in this condition, which could explain the lack of mitotic exit in this context.
Deletion of CDC55 has been reported to hyper-activate the FEAR network and cause
constitutive Cdc14 release in cdc20-blocked cells (Queralt et al., 2006). I observed
essentially the same scenario of co-spreading of both Cdc14-YFP and Net1-CFP in
cdc20- blocked cdc55Δ cells (data not shown).

ME is a complex system, governed by an interdigitated control network. Here, I
have attempted to elucidate the system with all major control parameters taken into
consideration in a balanced way, in order to gain an understanding of the relative
importance of various pathways in controlling ME. My results lead to the
conclusion that Cdk inactivation is absolutely required for ME.

In my analysis, Esp1

does not make a quantitatively major contribution to kinetics of ME beyond that due
to its ability to cleave cohesin.

Cohesin cleavage and consequent spindle elongation

strongly increases the speed and reliability of ME, most likely by allowing MEN
activation.
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12. Remaining issues from my experiments:

1. How is the MEN activated?

The prevailing model is that spindle elongation

pushes one SPB close to the bud cortex where Lte1 localizes. Lte1 can activate
GTPase Tem1 probably as its guanine exchange factor to induce the
Tem1-Cdc15-Dbf1 signaling cascade.

However, Let1 is not essential for cell

viability. There should be parallel mechanisms activating MEN by sensing anaphase.
It is also unclear whether SPB has to directly contact the bud cortex to activate MEN,
or just needs to get close to it. It has been reported that some proteins (like Kar9 and
Bim1) can travel along cytoplasmic microtubules.

It is imaginable that cell

polarization proteins (like Cdc42, Lte1, Ste20 et al.) might reach the SPB by traveling
along microtubules to activate Tem1 at the SPB.

2. Does Cdc14 localize differently in early and late mitosis in normal cell cycles?
My data and previous publications suggested that Cdc14 might localize in
nucleus/spindle in early mitosis, and switch to cytoplasm and bud-neck in later
mitosis. However, most experiments were performed with the cell cycle blocked by
various means.

It is important to know whether Cdc14 localization really follows

this rule in normal cell cycles.

3. What causes Cdc14 to return into nucleolus?

Although Cdc5 degradation by

Cdh1 has been reported to promote Cdc14 re-sequestration, in cycling cdh1Δ cells,
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Cdc14 resequestration was delayed by at most 3 minutes (i.e., any difference is at
frame resolution) in my single cell time-lapse analysis.

So there must be parallel

mechanisms promoting Cdc14 resequestration. Since both polo kinase and the MEN
are essential for Cdc14 release, inactivation of MEN may lead to Cdc14
re-sequestration.

My data showed that in the absence of Cdh1, mitotic cyclin-Cdk

activity can maintain Cdc14 in released state for 3 hours, indicating Clb-Cdk may
prevent MEN inactivation.
mitosis.

It is unclear how the MEN is inactivated at the end of

Cdc14 has been shown to dephosphorylate Bub2 to inactive the MEN.

The MEN could also be inactivated directly due to budding which translocates MEN
activators into the incipient bud.

Cdc14 can promote Lte1 delocalization from bud

cortex into cytoplasm at least under overexpression, pointing to another possible way
for MEN inactivation by Cdc14, though the causal relationship has yet to be
demonstrated.

One problem that makes it difficult to reason effectively on these issues is that it
remains unclear how the MEN and the FEAR network release Cdc14 from nucleolus.
One model suggests that Dbf2, Cdc5 and Cdk can phosphorylate Net1 and Cdc14 to
promote their disassociation, but solid evidence is still missing. Effective Cdc14
release could be coupled directly to nucleolar division, providing a direct cell
biological coupling between anaphase and ME.

This model could explain the

requirement I observed for intact microtubules for promotion of Cdc14 release by
Esp1.
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4. Cdc14 released by FEAR network has been shown to promote rDNA
segregation.

In my experiments, Clb2kd expression can delay rDNA segregation,

but not bulk DNA segregation, in single cell analysis.

Therefore,

phosphorylation/dephosphorylation may be a way to coordinate rDNA segregation
with anaphase, but the potential Cdk/Cdc14 targets are unknown.
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Chapter 4: Cell Cycle Control by
Phase-Locking: Study of the Cdc14 Release
Endocycle
1. Background information

The eukaryotic cell cycle is driven by oscillations in levels and activity of
cyclin-dependent kinase (Cdk) (Morgan, 2007). These oscillations are accompanied
by ordered progression of cell cycle events. There are at least two mechanisms to
ensure correct ordering of these events. Checkpoint surveillance mechanisms delay
subsequent events until previous ones are finished (Elledge, 1996; Weinert et al.,
1994).

However, checkpoints are dispensable for correct ordering of cell cycle

events, at least in budding yeast.

Order can be established independent of checkpoints by a ‘ratchet’-like
mechanism under direct control of cyclin-Cdk oscillations: initiation of an event is
triggered by high cyclin-Cdk, but completion of the event is inhibited by high
cyclin-Cdk (Nasmyth, 1996; Stern and Nurse, 1996). The consequence of this
regulation is that cell cycle events occur exactly once per cyclin-Cdk cycle in a
regular sequence.

There is abundant evidence for this mechanism in control of DNA

replication (Kearsey and Cotterill, 2003).

Division of regulatory function among

multiple cyclins complicates this simple picture; nevertheless, a generally similar
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ratchet-like mechanism may apply to many cell cycle processes, such as spindle and
bud morphogenesis (Bloom and Cross, 2007).

Ratchet control can be attained by many molecular mechanisms.

For the

proposed ratchet control of DNA replication, many different redundant mechanisms
coexist in any given species, and very different mechanisms can operate in different
species (Kearsey and Cotterill, 2003). Nevertheless, all ratchet mechanisms,
controlling any cell cycle process, have one unavoidable prediction: blocking the
cyclin-Cdk cycle by locking Cdk activity at any constant level should arrest a
ratchet-controlled process at a single defined step in its trajectory. The
dose-response of where the process arrests in response to cyclin-Cdk level is then
informative as to mechanism and the overall structure of the control system.

Some cell cycle events may occur cyclically and repetitively in the likely absence
of oscillation of mitotic cyclin-Cdk activity.

Examples include the SPB/centrosome

duplication cycles in budding yeast and various animal embryos, and the periodic
budding and cell-cycle-regulated transcription in budding yeast.

These

‘endocyclical’ events are not likely driven by oscillations of other cyclins (Gard et al.,
1990; Haase and Reed, 1999; Haase et al., 2001; McCleland and O'Farrell, 2008;
Sluder et al., 1990).

DNA endoreduplication could also be considered under this

category since it occurs in the absence of mitotic B-cyclin activity.

However, in this

case, a ratchet-like mechanism driven by other cyclins such as cyclin E has been
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proposed (Inze and De Veylder, 2006; Weiss et al., 1998).

On their face, these endocycles pose a significant challenge to the concept of
cyclin-Cdk-based ratchet control. However, the relevance of these endocycles to the
mitotic cell cycle, and what mechanism, if any, entrains them to mitotic cyclin-Cdk
cycles, remains unclear (Murray and Kirschner, 1989).

Recently, we carried out an analysis of dose-response of mitotic exit to locked
cyclin-Cdk activity levels, using titrated pulses of undegradable mitotic cyclin Clb2
and correlating steps of mitotic exit to Clb2 levels in individual cells (Drapkin et al.,
in press). High Clb2 levels have long been known to block mitotic exit (Surana et al.,
1993); however, we found that the peak level of Clb2-Cdk activity attained in a
normal cell cycle was inefficient at restraining multiple aspects of mitotic exit.
These results strongly suggested that the simple cyclin-based ratchet model accounted
poorly for control of mitotic exit, and a better fit was obtained by incorporating the
activity of Cdc14 phosphatase as a general cyclin-Cdk antagonist, capable of
dephosphorylating multiple cyclin-Cdk phosphorylation targets.

(This specificity is

consistent with structure and in vitro activity of Cdc14 (Gray et al., 2003)).

Effective regulation of Cdc14 localization and activity is probably essential for
normal cell cycle progression.

Cdc14 is restrained and inhibited in the nucleolus by

the constitutively nucleolar Net1 protein, except in mitosis (Shou et al., 1999; Visintin
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et al., 1999).

The spindle orientation checkpoint (SPOC, regulating the mitotic exit

network MEN) is an important regulator of Cdc14 release (Bardin et al., 2000; Pereira
et al., 2000; Stegmeier and Amon, 2004). Anaphase sends the daughter-oriented
spindle pole body (SPB) into the bud, activating the Tem1-Cdc15-Dbf2 MEN cascade
which promotes Cdc14 release and activation (Bardin et al., 2000). However,
removing the key SPOC inhibitor Bub2 has almost no effect on Cdc14 release in an
unperturbed cell cycle (data not shown), despite strong deregulation of SPOC function,
indicating the need for additional mechanisms to account for regulation of Cdc14
release, which is likely associated with cyclin-Cdk oscillations. Although
connections between Cdc14 release and Clb-Cdk activity have been described
(Azzam et al., 2004; Jaspersen and Morgan, 2000; Queralt et al., 2006; Stegmeier et
al., 2002), it is as yet unclear how Cdc14 localization responses to difference Clb
levels and whether these controls constitute a ratchet mechanism sufficient to lock
Cdc14 release to once per cell cycle.

In this work, I aim to understand how cyclin-Cdk activity controls Cdc14
localization and activity, and whether this control constitutes a ‘ratchet’ mechanism.
In initial experiments, I treated the Cdc14 control system as a ‘black box’, and to
study its input (cyclin-Cdk) – output (Cdc14 localization) relationship at various
mitotic cyclin levels.

Again, I used pulses of undegradable mitotic cyclin Clb2.

As

noted above, for a process under cyclin-Cdk ratchet control, this approach is predicted
to result in arrest of the process at a specific step defined by the locked cyclin-Cdk
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levels.

In exact contrast to this prediction, though, I observed Cdc14 cycling in and

out of the nucleolus multiple times at high but physiological fixed mitotic cyclin
levels.

These observations, along with other cell cycle endocycles reported previously
(see above), suggest that many cell cycle events have intrinsic ‘clocks’ controlling
their occurrence.

This concept stands in sharp contrast to the cyclin-Cdk-ratchet

model, and pose the question of how these events occur only once per Clb-Cdk cycle
and in a very specific sequence despite the ability to oscillate autonomously.

Based on my study of Cdc14 endocycles, I propose that the cyclin-Cdk oscillator
entrains (‘phase-locks’) other cell cycle oscillators.

Phase-locking is

well-established for circadian systems (as well as many other biological and physical
systems) (Glass, 2001). Extrinsically applied phase locking has been implemented
experimentally to control the timing of the budding yeast cell cycle (Charvin et al.,
2009).

My experiments and analysis suggest that Cdc14 localization, likely other cell
cycles events, is controlled by an intrinsically oscillatory module(s).

In wild-type

cell cycles, cyclin-Cdk oscillations phase-lock those oscillators to once-per-cell-cycle,
and the Cdk-response properties of those oscillators determine the timing and order of
downstream cell cycle events. The phase-locking model reconciles previous
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observation of autonomous oscillators with once-per-cell-cycle control of multiple
cell cycle events, and is compatible with experimental results from my study.
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2. Blocking mitotic exit with undegradable Clb2kd reveals
Cdc14 release endocycles

Cdc14-release status is not “all or none” but contains intermediate states
(Stegmeier et al., 2002). I designed a quantitative, single cell measurement for
Cdc14 localization based on variation of cellular Cdc14-YFP pixel intensities,
standardized to variation of nucleolar Net1-mCherry, which is an improved version of
my previous assay (Lu and Cross, 2009) (this Cdc14 release measure is
mathematically predicted to vary linearly with the fraction of Cdc14 released into
cytoplasm, Materials and Methods). Fig. 4.1A illustrates the measure applied to a
CDC14-YFP NET1-mCherry cell undergoing a normal Cdc14 release following
anaphase. I used Myo1-GFP as a budding and cytokinesis marker (Bi et al., 1998).
Since the bud-neck region was always manually excluded from quantification, the
Myo1-GFP signal didn’t interfere with Cdc14 measurements.
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Figure 4.1

Figure 4.1. Cyclical Cdc14 release uncoupled from cell cycle progression. A, B.
MET3-CDC20 CDC14-YFP NET1-mCherry MYO1-GFP cells were released from a
MET3-CDC20 block (t=0). Bottom: Cdc14 release was quantified at each time point.
Triangle: Myo1 ring. Scale bar: 5 microns. A: control. B. Clb2kd was pulsed for 30
minutes before release. C. Schematic of procedure for loading cells with
undegradable Clb2kd (green) before ME. Nucleolus is shown in red.

D. Pulsed

Clb2kd-GFP was quantified (right column) in units standardized to the peak level of
Clb2 attained in a normal cell cycle, and Cdc14 release quantified.

Blue bars:

anaphase (nucleolar separation, marked by Net1-mCherry); Red bars: cytokinesis
(Myo1 ring disappearance); green bars: bud emergence. E. CLN2 promoter
expression during Cdc14 endocycles. A CLN2pr-GFP-PEST strain was pulsed with
Clb2kd as in (B) for 35 minutes.

GFP intensities at the first Cdc14 release,

maximum during endocycles (n=40), and at rebudding in unpulsed control cells
(P<10-15. Error bars: standard deviation).
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I followed a procedure described in ‘Materials and Methods’ to load cells with
physiological levels of stable Clb2 during a pre-anaphase block, and then release the
block and examine events of mitotic exit in single cells as a function of Clb2 level.

I

blocked cells in metaphase by depleting the essential anaphase-promoting complex
(APC) activator Cdc20, by shutoff of MET3-CDC20 (Sullivan et al., 2001).

Cdc20

promotes proteolysis of the separase inhibitor Pds1, driving anaphase, and promotes
initial proteolysis of B-type cyclins (Shirayama et al., 1998; Wäsch and Cross, 2002;
Yeong et al., 2000) ; later in mitosis and in G1, B-type cyclin proteolysis is
maintained by the related Cdh1 activator (Schwab et al., 1997).

I transiently pulsed

these cdc20-blocked metaphase cells with Clb2kd; Clb2kd lacks the Clb2 destruction
and KEN boxes recognized by Cdh1 and Cdc20, and is therefore almost completely
stable (Wäsch and Cross, 2002)). Clb2kd was labeled with GFP to allow single-cell
quantification of Clb2kd levels.

This procedure yielded a population with variable

levels of stable Clb2kd-GFP, averaging around the peak Clb2-GFP level in a
wild-type cell cycle (I refer to this level as ‘1X peak’ Clb2kd; accurate single-cell
quantification of Clb2kd levels in these units has been documented elsewhere
[Drapkin et al, in press]).

Re-inducing MET3-CDC20 induced anaphase, which proceeded on schedule
independent of stable Clb2kd-GFP (data not shown). Clb2kd-GFP was stable after
expression, only being slowly diluted with cell growth (Fig. 4.2). Clb2kd-associated
kinase activity was essentially constant through this protocol (Drapkin et al, in press).
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I assayed post-anaphase ME events as a function of single-cell Clb2kd-GFP levels
(Fig. 4.1C), using quantitative time-lapse microscopy.

~1X peak Clb2kd-GFP and above induced dose-dependent delays in cytokinesis
and bud emergence (Drapkin et al., in press; Fig. 4.3). In contrast, Cdc14-YFP was
released from the nucleolus and subsequently resequestered, with essentially normal
kinetics up to at least 3X peak Clb2kd-GFP concentrations (Fig. 4.1D and Fig. 4.4;
Drapkin et al., in press).

Strong overexpression of stable Clb2 was shown previously

to cause extended Cdc14 release.

I confirmed this observation by constitutively

overexpressing GAL1-CLB2kd in galactose medium, which results in at least 10-fold
peak Clb2kd levels (Fig. 4.5).

I assume that results at approximately physiological

Clb2kd levels are more biologically relevant, and I have not pursued the basis for the
effect of extreme Clb2kd overexpression on Cdc14 release.

Remarkably, cells with moderately more than 1X peak Clb2kd-GFP frequently
exhibited multiple cycles of Cdc14-YFP release and resequestration, before finally
undergoing cytokinesis and rebudding (Fig. 4.1B,D).
endocycles’.
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I call these ‘Cdc14

Figure 4.2

Figure 4.2. Clb2kd-GFP is stable in vivo. GAL1-CLB2kd-GFP was pulsed for 30
minutes as described in Materials and Methods. The average GFP intensity inside a
cell was measured, and ploted in the upper panel. 4 traces were picked up to plot in
the lower panels. Fitting the GFP curve with an exponential decay function, we obtain
the median decay constant of 112 minutes.
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Cells exhibiting Cdc14 endocycles did not show overt cell cycle progression as
determined by budding, cytokinesis, or nuclear or nucleolar division.

The G1 cyclin

CLN2 is expressed at cell cycle Start, as part of a large regulon (Wittenberg et al.,
1990).

To examine whether some aspects of cell cycle progression were proceeding

despite the absence of morphological events, I examined CLN2 promoter activity
using a CLN2pr-GFP-PEST construct (Bean et al., 2006; Mateus and Avery, 2000) as
a molecular marker for cell-cycle progression in Clb2kd-blocked cells. I observed no
significant CLN2pr expression while cells were undergoing Cdc14 endocycles, while
a burst of CLN2pr expression occurred when these cells finally budded (Fig. 4.1E).
This result also implies that the Cdc14 endocycle is not driven by oscillations in G1
cyclin expression (also see below).
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Figure 4.3

Figure 4.3. Clb2kd-GFP activity leads to graded delay in rebudding.
GAL1-CLB2kd-GFP strain was treated as in Fig. 4.1D. The rebudding time was
plotted against Clb2kd-GFP concentration for each cell. Red line shows a fitting with
a linear function (r=0.8, p=8x10-4). The average rebudding time for unpulsed cells
was shown with a dashed grey line.
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Figure 4.4

Figure 4.4. Height and width of Cdc14 release peak are not affected by
Clb2kd-GFP concentration up to 3-fold wild-type peak level.

Cells were treated

as in Fig. 4.1D. In cases of Cdc14 endocycles, the height and width of the release
peak is plotted against Clb2kd-GFP concentration. Cdc14 release in wildtype cells
lasts for about 20 minutes.
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Figure 4.5

Figure 4.5. Comparison of Clb2(kd) levels under various conditions.

Asy:

asynchronous culture; GAL-CLB2kd: asynchronous culture of GAL-CLB2kd strain
growing in raffinose. Galactose is added at time zero. MET-CDC20: MET-CDC20
strain in R+MET; CLB2kd:CLB2kd strain is first synchronized with alpha factor in
galactose medium, and is released into either glucose or galactose (t=0). Numbers
under lanes: Clb2/Pgk1 value, normalized by the value for asynchronous culture.
Numbers in bracket: Adjusted Clb2/Pgk1 value. Anti-Clb2 antibody recognizes Clb2
and Clb2kd with different affinity. We calibrate the Clb2 antibody using Clb2-YFP
and Clb2kd-YFP, obtaining the correction factor ~2.0 (Clb2/Clb2kd).
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In yeast, the MCM replicative helicase complex is excluded from the nucleus
throughout the cell cycle except for late M and G1, and this regulation contributes to
preventing pre-replicative complex formation except during these cell cycle stages
(Kearsey and Cotterill, 2003).
ME.

Mcm2-GFP nuclear relocalization occurs sharply at

~1X peak Clb2kd-YFP was sufficient to completely block Mcm2-GFP nuclear

accumulation before rebudding in the next G; lower levels of Clb2kd-YFP strongly
but incompletely inhibited Mcm2 nuclear reentry (Fig. 4.6; Drapkin et al., in press).
Consistent with this observation, I observed little or no DNA endoreduplication
during Cdc14 endocycles by DNA flow cytometry (no accumulation of 4C peak,
which would indicate an extra round of replication in undivided cells; Fig. 4.7).
These observations confirm continuous high Clb2kd-associated kinase activity in vivo,
and further confirm absence of molecular markers of cell cycle progression during
Cdc14 endocycles.

Despite constancy of Clb2kd levels and activity through this protocol (see above,
and Drapkin et al., in press), I needed to determine whether endogenous mitotic
cyclins might be oscillating and potentially controlling Cdc14 localization in cells
exhibiting Cdc14 endocycles.

I tagged endogenous Clb2 with GFP in

GAL1pr-CLB2kd cells, and found that Clb2-GFP was uniformly degraded after the
initial Cdc14 release regardless of Clb2kd levels.

Clb2-GFP signal remained at the

basal level through the period of Cdc14 endocycles, only reaccumulating upon exit
from the endocycling state and re-entry into the next cell cycle (Fig. 4.8). Thus, the
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Cdc14 endocycle is most likely not driven by endogenous mitotic cyclin oscillations.

Cdc14 endocycles are not driven by oscillations of stoichiometric inhibitors of
Cdk, such as Sic1 (Verma et al., 1997), because pulsed Clb2kd was associated with
constant histone H1 kinase activity, and Sic1 levels stayed low, and insufficient for
Clb2kd inhibition, during the protocol (Drapkin et al. in press). Consistently, Cdc14
endocycles were independent of Swi5, the major SIC1 transcription factor (Toyn et al.,
1997)(Fig. 4.9).

Overall, I conclude that Cdc14 release endocycles were not driven by oscillations
of Clb2kd or Clb2-Cdk activity, and was likely independent of endogenous G1 or
mitotic cyclins. Cdc14 endocycles were observed in cells that failed to undergo cell
cycle progression, as indicated by failure of cytokinesis, rebudding, Mcm complex
nuclear reaccumulation, DNA replication, G1 cyclin expression and endogenous Clb2
reaccumulation.
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Figure 4.6

Figure 4.6. The response of Mcm2 nuclear localization to Clb2kd. MCM2-GFP
cells was pulsed with GAL1-CLB2kd-YFP for 30 minutes as in Fig. 4.1D, and released
into cell cycle progression.

Coefficient of Variation(CV) of Mcm2-GFP in a single

cell was used as a proxy for Mcm2 nuclear localization. An increase of CV indicates
an increase of Mcm2-GFP nuclear concentration. Top four traces show
CV(Mcm2-GFP) during the time course under various Clb2kd-YFP concentrations in
the ‘peak’ unit (Materials and Methods). Bottom panel shows the height of
CV(Mcm2-GFP) peak before budding vs. Clb2kd-YFP levels for both unpulsed
control and pulsed cells. Note: due to cellular background fluctuations, the apparent
‘Clb2kd-YFP’ level for unpulsed controls is not strictly zero. Blue bars: anaphase;
green bars: budding.
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Figure 4.7

Figure 4.7. MET-CDC20 CDC15/cdc15-2 cells were pulsed with GAL1-Clb2kd for
35 minutes at 28° permissive temperature before released from cdc20- block. After
incubated at 28° for 40 minutes to allow anaphase and initial Cdc14 release, cultures
were shifted to 37° restrictive temperature (t=0). FACS samples showing DNA
content were taken at indicated time points.
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Figure 4.8

Figure 4.8. Endogenous Clb2 was degraded regardless of Clb2kd, and did not
accumulate during Cdc14-release endocycles. GAL1-CLB2kd was pulsed for 35
minutes in cells whose endogenous Clb2 was tagged with GFP. Cdc14 release curve
(blue) and GFP signal (green) were shown for 4 examples.

In the case of Cdc14

release endocycles (lower two panels), Clb2-GFP signal remained low during the
oscillation period (n=36). Vertical blue bar: nucleolar separation (anaphase); Vertical
red bar: cytokinesis; Vertical green bar: bud emergence.
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Figure 4.9

Figure 4.9. Cdc14 endocycle is not disrupted by SWI5 deletion.
GAL1-CLB2kd-GFP was pulsed for 30 minutes in swi5∆ cells before observation.
representative samples show that Cdc14 endocycles persisted in swi5∆ cells(n=66).
The number on each panel is Clb2kd-GFP concentration in the ‘peak’ unit (Materials
and Methods). Blue bars: anaphase; Green bars: budding; Red bars: cytokinesis.
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3. Clb2kd levels quantitatively control the frequency of the
Cdc14 release endocycle

Cdc14 release cycles exhibited an interesting dose-response to Clb2kd. In cells
with a relatively low level of Clb2kd-GFP (less than ~0.5X peak), cell-cycle
progression was not greatly disturbed, and a single cycle of Cdc14 release and
resequestration followed anaphase (marked by nucleolar Net1 separation), as in
normal cell cycles (Fig. 4.10A, category 1).

Cdc14 release in the next cell cycle of

‘category 1’ cells was frequently delayed, possibly due to 2nd-cycle defects caused by
low Clb2kd (Drapkin et al. in press). At intermediate levels of Clb2kd-GFP (around
0.75X peak), cytological ME was delayed but not blocked by Clb2kd, as reported
(Drapkin et al., in press).

In some of these cells, a 2nd Cdc14-release event occurred

rapidly after bud emergence, without an associated anaphase (Fig. 4.10A, category 2).
At >=1X peak Clb2kd concentrations, the 2nd (and frequently additional) Cdc14
release/resequestration cycles happened without cytokinesis, rebudding, CLN2pr
expression or any other markers of cell cycle progression; these category 3 cells
exhibits the endocycle phenotype characterized above (Fig. 4.10A, category 3).
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Figure 4.10. Clb2kd level controls the Cdc14 endocycle period.

A. Trajectories

for Clb2kd-pulsed cells. Category 1: essentially normal cell-cycle progression (though
with 2nd cycle Clb2kd-induced delays; Drapkin et al., submitted); Category 2: a
second Cdc14 release occurred between rebudding and nucleolar separation in the
next cell cycle; Category 3: Cdc14 endocycles without cytokinesis or rebudding.
Below: category means and standard deviations of Clb2kd-GFP concentration (blue)
and Cdc14 release intervals (red) . B. Cdc14 release frequencies plotted against
Clb2kd-GFP level for cell categories: inverse of intervals between first and second
Cdc14 release (categories 1 and 2), or average frequencies of one cell’s Cdc14
endocycles (category 3).

Shaded: range of cell cycle frequencies for cycling

MET3-CDC20 mother cells.

121

Figure 4.10
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It is interesting to note that category 2 cells represent an intermediate phenotype
between normal tight linkage of Cdc14 release to cell cycle progression, and complete
uncoupling as in category 3 endocycling cells. Therefore, there is likely a
continuous transition from normal Cdc14 release cycles to endocycle phenotypes with
increasing Clb2kd concentrations.

By plotting the frequencies of Cdc14-release oscillation versus the concentration
of Clb2kd-GFP, I observed a positive correlation below ~1.7x peak Clb2kd
concentration (P<2*10-7, using only data from cells that undergo endocycles without
apparent cell cycle progression; ‘category 3’ in Fig. 4.10.

A quantitatively similar

and highly significant positive correlation was observed using all three categories of
cells).

This continuous response across the different phenotypic categories suggests

that frequency of Cdc14 release may be directly controlled by Clb2 levels,
independent of occurrence of some events of cell cycle progression.

At higher

Clb2kd, the endocycle frequency saturated at about once every 45 minutes (Fig.
4.10B).

For simplicity, I fitted this correlation with a linear step function. This

correlation is highly significant, and the slope determined with rather narrow
confidence intervals (Fig. 4.10B legend).

There is obviously very considerable noise

about this linear fit, which could be due to the intrinsic heterogeneity in the cell
population. In what follows, I will make use solely of the average dose-response
relationship.

123

Although the frequencies of Cdc14 release cycles were positively controlled by
Clb2kd, the amplitude and duration of Cdc14 release (whenever it occurred) did not
significantly correlate with Clb2kd-GFP concentration (Fig. 4.4).

These quantitative observations are important for my theoretical analysis below.
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4. Requirement for Cdc14 release endocycle

A free-running oscillator may drive G1 events in the absence all B-type cyclins
(Haase and Reed, 1999; Orlando et al., 2008).

It was important to determine if this

oscillator might also drive Cdc14 endocycles. To test this, I overexpressed a stable
Clb-Cdk inhibitor Sic1-4A from a GAL1 promoter to inhibit all B-type cyclin-Cdk
activity (Verma et al., 1997).

Multiple budding without cell division (manifesting

the free-running G1 oscillator, as described (Haase and Reed, 1999)) was observed
following Clb inhibition.

However, I did not detect any Cdc14-release events in a 6

hour time-course in these cells (Fig. 4.11) (this result, when compared to the Clb2kd
results, also has the interesting implication that Cdc14 release endocycles may have a
minimum ‘permissive’ level of mitotic cyclin activity required for their occurrence).
Conversely, to test if Cdc14 was an essential component for the G1 oscillator, I
constructed a strain harboring a temperature-sensitive mutant of cdc14-1 with all
B-cyclin deleted.

I counted the multiple-budding phenotype in a time-course

experiment from small G1 cells by elutriation, and found that cdc14-1 cells formed a
second bud as efficiently as wild-type cells (Fig. 4.12).

Therefore, I conclude that

the Cdc14 release and G1 endocycles are driven by distinct and independent
mechanisms.

The mitotic exit network (MEN) is a major regulator of Cdc14 release during late
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anaphase (Stegmeier and Amon, 2004).

Cdc14 endocycles required the MEN

component Cdc15, even after allowing an initial round of Cdc14 release (showing that
the MEN is required for maintenance as well as initiation of endocycling) (Fig.
4.13D).

The FEAR network is involved in a transient wave of early anaphase Cdc14

release (Stegmeier et al., 2002); Cdc14 endocycles did not require the FEAR network
component Spo12, or Net1 phosphorylation by Clb-Cdk, a key event in FEAR
pathway activation (Azzam et al., 2004; Queralt et al., 2006) (Fig. 4.14). In bub2Δ
cells, MEN activity is likely to be near-constitutive (Alexandru et al., 1999; Pereira et
al., 2000; Xu et al., 2000).

The Cdc14 release endocycles persisted in bub2Δ cells in

the presence of Clb2kd (Fig. 4.14), suggesting that the Cdc14 endocycle may not be
driven by oscillations of MEN activity.
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Figure 4.11

Figure 4.11. Cdc14 release did not happen in Sic1-4A expressing cells.
GAL1-SIC1-4A cells were grown in raffinose medium, then transfered to galactose
medium to make time-lapse movies (t=0). No Cdc14 release was detected during the
experiment except in the initial cell cycle.

14 independent cells are shown here

(n=36).
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Figure 4.12

Figure 4.12. The budding endocycle in clb1~6∆ cells was independent of
Cdc14. clb1~6∆ GAL1-CLB2 swe1∆ with CDC14 or cdc14-1 was grown in
galactose medium at 23˚. Small G1 cells were collected through elutriation, and
released into glucose medium at 37˚. Cells were harvested and counted for
multi-budding phenotype at indicated time points.
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Figure 4.13. Requirements for Cdc14 endocycles.

A. As in Fig. 4.1B, but cells

also cdc5::3XCDC5ΔNT . Among cells whose rebudding was delayed for at least 25
minutes (implying >1X peak Clb2kd, Fig. 4.3), 19/36 cells showed fast Cdc14 release
and resequestration, followed by prolonged Cdc14 release. 8/36 showed only
prolonged Cdc14 release. B. As in Fig. 4.1D, but also cdh1Δ; 30 min Clb2kd-GFP
pulse; typical traces for the indicated Clb2kd-GFP ranges.

Among cells with >1X

peak Clb2kd-GFP (n=86), 41% showed a prolonged Cdc14 release period (middle
two traces); 43% (cells with highest Clb2kd-GFP) showed release endocycles with a
reduced amplitude (bottom trace); Blue bars: anaphase; Red bars: cytokinesis; green
bars: bud emergence.

C. CDC5pr-GFP cells, as in Fig. 4.1B. Trough GFP

intensities before rebudding plotted against rebudding times; rebudding delay
indicates Clb2kd levels; sample traces below. D. Cells as in Fig. 4.1D, but also
cdc15-2 or cdc5-1; after 35 min to allow initial Cdc14 release, cells were plated for
time-lapse at 37oC (restrictive temperature) (t=0).

CHX: as above, except that

time-lapse medium contained 0.2ng/μl cycloheximide (CHX). Among cells with >1X
peak Clb2kd-GFP, 18/24 CDC15 CDC5 cells, 0/22 cdc15-2, 0/30 cdc5-1 and 3/64
cells in CHX exhibited Cdc14 release endocycles..

Blue bars: anaphase; green bars:

bud emergence. E: As in Fig. 4.1B, but CDC5-GFP cells; 30 min Clb2kd pulsed;
typical traces of Cdc14 release and Cdc5-GFP levels are shown.

In 36/45

Cdc14-endocycling cells, Cdc5-GFP signal oscillated in-phase with Cdc14 release.
F. ODE model simulating Cdc14-Cdh1-Cdc5 negative feedback (Materials and
Methods).
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Figure 4.13
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Polo kinase Cdc5 is essential for Cdc14 release, in both the FEAR and MEN
pathways, and Cdc5 overexpression can drive ectopic Cdc14 release in
S-phase-blocked cells (Visintin et al., 2003).

Using a cdc5-1 temperature-sensitive

mutation, I determined that Cdc5 activity was absolutely required for maintenance of
Cdc14 endocycles (Fig. 4.13D).

Thus, Cdc14 endocycles in Clb2kd-blocked cells share requirements with normal
late-anaphase Cdc14 release, supporting the idea that the endocycles may involve
mechanisms controlling Cdc14 release in the free-running cell cycle.

Cdc14 endocycles in Clb2kd-blocked cells require resequestration into the
nucleolus after each release.

Cdc5 is essential for normal Cdc14 release, and Cdc5 is

down-regulated at the end of mitosis by inactivation of its transcription and by
Cdh1-APC-dependent proteolysis (Charles et al., 1998; Shirayama et al., 1998); Cdc5
proteolysis contributes to Cdc14 resequestration into the nucleolus (Visintin et al.,
2008). Therefore, to ask if resequestration in endocycles shared requirements with
resequestration in the free-running cycle, I tested Cdh1-resistant Cdc5-ΔNT (using 3X
CDC5-ΔNT, an allele that produces near-wild-type Cdc5 kinase levels, without
proteolytic regulation of Cdc5 protein abundance (Visintin et al., 2008)). 3X
CDC5-ΔNT severely inhibited Cdc14 endocycles.

In 3X CDC5-ΔNT cells deduced

to contain >1X peak Clb2kd, I did not detect multiple Cdc14 release endocycles.
Instead, 22% of cells showed an extended Cdc14 release period, and 52% of cells had
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a short Cdc14 release/re-sequestration cycle prior to a long release period (Fig. 4.13A).
As noted above, the release period in Cdc14 endocycles in CDC5+ cells are of normal
duration and amplitude, unlike the very long release periods in 3X CDC5-ΔNT cells.

CDH1 is required for cell-cycle-regulated Cdc5 degradation. Consistent with
results with CDC5-ΔNT, cdh1Δ but not CDH1 cells containing 0.5X to 2X peak
Clb2kd released Cdc14 for up to 80 minutes, and did not exhibit Cdc14 endocycles
(Fig. 4.13B).

Surprisingly, however, I observed Cdc14 endocycles in cdh1Δ cells

with > 2X peak Clb2kd, but release was incomplete (about half the normal amplitude)
(Fig. 4.13B).

This result indicates the existence of a parallel Cdh1-independent

pathway allowing Cdc14 endocycles; but the primary mechanism likely requires
Cdh1-dependent proteolysis of Cdc5, dependent on the Cdc5 N-terminal destruction
box.
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Figure 4.14

Figure 4.14. Cdc14 endocycles occured in spo12∆, net1-6Cdk, bub2∆ cells.

All

three strains contain MET-CDC20 CDC14-YFP NET1-mCherry MYO1-GFP
GAL1-CLB2kd-GFP GAL4-rMR with additional genotypes indicated above.
Cultures were pulsed with Clb2kd-GFP for 30 minutes, and subjected to time-lapse
microscopy analysis as in Fig. 4.1D.

Unpulsed controls are shown in the top row.

bub2∆ cdc15-2 cells were arrested and pulsed at 34°, and released at 27° (Using
cdc15-2 is to achieve a stable arrest at cdc20-). Among cells with >1X peak
zation.pdf</url></pdf-urls></urls><language>eng</language></record></Cite></En
dNote> (Visintin et aphenotypes.
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5. A Cdc14-Cdh1-Cdc5 negative feedback mechanism
contributes to Cdc14 endocycle

Cdc14 endocycles are abrogated either by loss of Cdc5 (in cdc5-1 cells), or by
blocking Cdc5 degradation, presumably increasing Cdc5 levels (in CDC5-ΔNT or
cdh1Δ cells).

This could reflect a requirement for cyclical Cdc5 activity for Cdc14

endocycles, since they are prevented by either constitutively high or constitutively
low Cdc5.

I hypothesized that mitotically active Cdc5 would promote Cdc14 release, Cdc14
would activate Cdh1 leading to Cdc5 proteolysis, and Cdc14 would reaccumulate in
the nucleolus.

In the wild-type cell cycle, Cdc5 cannot reaccumulate until the next

M-phase: CDC5 is co-transcribed with CLB2 under Clb2-dependent positive feedback
control (Wittenberg and Reed, 2005), so Clb2 removal at anaphase blocks further
CDC5 transcription.

In addition, absence of Cdk activity in G1 keeps Cdh1 active

until later cyclin-Cdk reactivation. In Clb2kd-blocked cells, though, persistent
Clb2kd could both maintain CDC5 transcription, and inactivate Cdh1, in the absence
of counterbalancing dephosphorylation by Cdc14, allowing rapid reaccumulation of
Cdc5 and endocyclic Cdc14 release and resequestration.

This negative feedback

hypothesis would explain the absence of endocycles in cdc5-1, CDC5-ΔNT and cdh1Δ
cells.
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Consistent with this hypothesis, I observed higher trough levels and rapid rebound
of CDC5 transcription in Clb2kd-pulsed cells compared to unpulsed controls (Fig.
4.13C), using a cell-cycle-regulated CDC5pr-GFP reporter (J. Skotheim, pers.
comm.).

Also consistent with the hypothesis, Cdc14 endocycles required new protein
synthesis, since endocycles were blocked by addition of cycloheximide after an initial
Cdc14 release (Fig. 4.13D). Finally, in cells undergoing Cdc14 endocycles, I observed
cyclical accumulation and degradation of Cdc5-GFP fusion protein expressed from
the endogenous promoter, in approximately the expected phase relative to Cdc14
release (Fig. 4.13F).

A qualitative ODE model (Fig. 4.13E) of a Cdc5-Cdc14-Cdh1 negative feedback
loop reproduced my major qualitative results, including dependence of Cdc14
endocycle frequency on Clb2kd concentrations (Fig. 4.10B; Fig. 4.15).
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Figure 4.15

Figure 4.15. Cdc14 endocycle frequency vs. Clb2kd level by ODE simulation.
Clb2kd concentration was changed continuously as a parameter in the ODE model
simulating Cdc5-Cdc14-Cdh1 negative feedback (Materials and Methods).
release frequency was calculated from the simulation.
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Cdc14

This negative feedback mechanism is probably the main but not the only source of
Cdc14 endocycles.

Cdh1-dependent Cdc5 degradation cannot be strictly essential

for resequestration, since resequestration was delayed but not blocked in CDC5-ΔNT
and cdh1Δ cells, and I observed low-amplitude endocycles in cdh1Δ cells at very high
(>2X peak) Clb2kd levels.
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6. An intrinsic oscillatory module may control normal
Cdc14 release in unperturbed cell cycles

I used cell cycle block with undegradable Clb2 to demonstrate an oscillatory
module controlling Cdc14 localization in the absence of cyclin-Cdk oscillations.

The emergence of Cdc14 release endocycles at high (but physiological) Clb2kd
levels could come about because Clb2kd accelerates the Cdc14-release-control
module (Fig. 4.10B) and greatly delays Clb-Cdk oscillation, temporally separating
these oscillators.

Mechanistically, acceleration of the Cdc14 module could derive

from rapid rebound of the Cdc5-Cdc14-Cdh1 negative feedback oscillator with high
locked Clb2 levels (see above); the stalling of the Clb-Cdk oscillation is a direct
consequence of blocking Clb2 degradation.

Cdc14 endocycle phenotypes are only of clear physiological importance only if
this module and its self-oscillatory behavior are coupled to normal Cdc14 release in
unperturbed cell cycles. However, any experiments trying to reveal the module’s
intrinsic behavior will inevitably perturb normal cell cycle progression. Therefore, I
try to answer this question in two steps: 1. whether the Cdc14-release module can
oscillate autonomously in free-running cell cycles; 2. whether normal Cdc14 release
cycles are also promoted by self-oscillatory behavior of this module.
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To study the

first question, I looked for ways to uncouple the hypothetical Cdc14 oscillatory
module from the Clb-Cdk oscillator, without blocking the cell cycle.

Genetic

manipulations providing sufficient uncoupling could allow detection of Cdc14 release
endocycles in a free-running cell cycle. Plausible coupling components include: 1.
CDC5 transcription, activated by Clb-Cdk; 2. Cdh1, activated by Cdc14 and
degrading Clbs and Cdc5; 3. the MEN, indirectly activated by mitotic cyclin-Cdk,
since anaphase (promoted by cyclin-Cdk (Fitch et al., 1992)) in turn activates the
MEN (Fig. 4.16).
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Figure 4.16. Cdc14 release endocycles in free-running cell cycles or with low
Clb2kd.

A. Cdc14 release and Clb-Cdk control mechanisms. Left: potential

autonomous Cdc14 release oscillator; right: Clb-Cdk negative-feedback oscillator.
SPOC: spindle orientation checkpoint. B. Cdc14 release analyzed as in Fig. 4.1D, in
bub2Δ cdh1Δ and GAL1-URL-CDC5 cells (cycling cells, without cdc20 block-release
or Clb2kd pulse).

A representative lineage (M0: mother, D1, D2...sequential

daughters) exhibiting ectopic Cdc14 release (red) before bud emergence.

Cdc14

release curves shifted for visualization. Below: frequencies of G1 Cdc14 endocycles.
C. 67μM Latrunculin-B (LAT-B) was added to the medium (t=0) to inhibit budding of
a cycling bub2Δ cdh1Δ strain.

32/44 cells demonstrated G1 Cdc14 endocycles.

14/19 daughter cells and 13/19 mother cells exhibited endocycles (maximum 4
endocycles; average=2.8).

D. MET-CDC20 bub2Δ cdc15-2 cells were arrested in

metaphase at 34℃ and pulsed with Clb2kd-GFP for 20 minutes (using cdc15-2 is to
achieve a stable cdc20- block), then released into cell cycle at 27℃ with 67μM
LAT-B to observe. The first anaphase (nucleolar separation) happened with normal
kinetics. LAT-B effectively blocked budding, cytokinesis, and all subsequent anaphase
in ~90% cells. 39/46 cells containing 0.2~1.0x peak Clb2kd-GFP demonstrated Cdc14
endocycles. Four traces are shown. The ‘Cdc14 endocycle frequency vs. Clb2kd-GFP
levels’ information is plotted together with the data in Fig. 4.10B. Blue bars: anaphase;
green bars: budding.
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Figure 4.16
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Following this reasoning, I tested the effects of making CDC5 transcription
independent of Clb-Cdk, using a GAL1-URL-CDC5 construct (Visintin et al., 2008);
the destabilizing URL tag was required to keep Cdc5 at a non-lethal level).
GAL1-URL-CDC5 cells are fully viable in galactose medium.

Consistent with the

oscillatory module hypothesis, I observed a G1-specific Cdc14 release endocycle in
~70% of daughter cells (Fig. 4.16B).

The observation of Cdc14 endocycles in G1 is

completely unexpected on the basis of any model involving ratchet-type control by
cyclin-Cdk.

(G1 cells stably contain almost no cyclin-Cdk activity (Mendenhall and

Hodge, 1998), so any event controlled by a cyclin-Cdk ratchet event has no basis for
repeated activity in G1 cells).

Deletion of CDH1 could also be predicted to weaken the coupling.

However, I

did not observe Cdc14 endocycles or Cdc14 release anomalies in cycling cdh1Δ cells.
One explanation for this could be that Cdh1 plays an important role not only in
coupling, but in the Cdc14 intrinsic oscillatory mechanism itself (see above; Fig.
4.13B).

My data suggest, though, that Cdh1 is not absolutely essential for Cdc14

cycles, since Cdc14 resequestration is eventually observed in Clb2kd-pulsed cdh1Δ
cells, and at high Clb2kd levels, low amplitude Cdc14 endocycles re-emerge.

If this

idea is correct, more complete decoupling could reveal Cdc14 release endocycles in
the absence of Cdh1, if they can be driven by parallel coupled pathway(s). I further
reduced the coupling by deleting BUB2, removing an MEN inhibitor that keeps MEN
activation dependent on anaphase (Fesquet et al., 1999; Pereira et al., 2000), and thus,

142

indirectly, dependence on mitotic cyclins that are required for anaphase (Fitch et al.,
1992).

Similar to GAL1-URL-CDC5 cells, I observed G1-specific Cdc14 release

endocycles in cycling cdh1Δ bub2Δ cells (again only in daughter cells and with
incomplete penetrance) (Fig. 4.16B).

BUB2 deletion slightly increased the

penetrance of Cdc14 endocycle phenotypes in GAL1-URL-CDC5 cells (Fig. 4.16B;
4.17), but did not alone induce endocycles (data not shown). CDC5-ΔNT in a CDH1
BUB2 background also induced G1 Cdc14 endocycles (Fig. 4.18).
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Figure 4.17

Figure 4.17. Cdc14 endocycles in G1 bub2∆ cdc5::GAL1-URL-CDC5 cells.
Asynchronous bub2∆ cdc5::GAL1-URL-CDC5 cells were grown in galactose medium
and subjected to time-lapse microscopy analysis. Two examples here show Cdc14
release endocycles in G1 daughter cells.

Traces are shifted along Y-axis for

presentation. In the whole population, 61% daughter cells show the endocycle
phenotype(n=18). Only 9% mother cells show this phenotype(n=22). The mother cell
M0 gave rise to the first daughter cell D1, and the second daughter cell D2. Blue bar:
anaphase; green bar: budding.
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Figure 4.18

Figure 4.18. Cdc14 endocycles in G1 cdc5::3xCDC5∆NT cells. Log phase
cdc5::3xCDC5∆NT culture was subjected to time-lapse microscopy analysis. An
example shows Cdc14 release endocycles in a G1 daughter cell (D2). The mother cell
M0 gave rise to the first daughter cell D1, then the second daughter cell D2. In the
whole population, 23% daughter cells showed the endocycle phenotype in G1 (red;
n=21); Only 3% mother cells showed this phenotype (n=30). Traces were shifted
along Y-axis for presentation. Blue bars: anaphase; green bars: budding.
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The daughter-preference of the endocycle phenotype could be due to
G1-cyclin-dependent relocalization of MEN activators such as Lte1 to the incipient
bud (Jensen et al., 2002), thus sequestering these activators until spindle pole entry
into the bud in the next cell cycle. Mothers bud and express G1 cyclins much earlier
than daughters (Di Talia et al., 2007), which could forestall any G1 Cdc14 endocycles,
explaining the observed daughter preference of endocycles. Actin depolymerization
with latrunculin B prevents budding; G1-cyclin-dependent Lte1 relocalization to the
cortex still occurs but cortex-bound Lte1 cannot be sequestered in a bud (Jensen et al.,
2002).

Addition of latrunculin B to cdh1Δ bub2Δ cells allowed Cdc14 endocycles in

G1 mothers as well as G1 daughters with equal probability (Fig. 4.16C).

I observed

up to four cycles of Cdc14 release and resequestration in these cells, in most cases
without associated anaphase.

These results establish that the genetic network controlling Cdc14 localization has
the intrinsic ability to oscillate even in free-running cell cycles.

This demonstration

required some alteration of normal control circuits, leaving the question open as to
whether the Cdc14-release control module still exhibits self-oscillatory behavior when
promoting normal Cdc14 release cycles in wild-type cells. There are some
suggestions in the data so far presented that this could be the case.

First, ’category 2’

cells described above form an intermediate phenotype in a continuous transition from
normal Cdc14 release cycles to the endocycle phenotype (Fig. 4.10A and text).

The

simplest explanation is that normal Cdc14 cycles and endocycles are driven by the
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same network whose kinetic parameters are tuned by mitotic cyclin activity. Second,
my estimate of the frequency of Cdc14 release oscillation at approximately mid-cell
cycle Clb2 levels, by extrapolation, is ~95 minutes, i.e., close to the normal cell cycle
frequency (Fig. 4.10B). Third, genetic requirements for Cdc14 endocycles and for
normal Cdc14 release are similar. Both required Cdc5 and Cdc15, and shared a
requirement for Cdh1-dependent degradation of Cdc5 for efficient Cdc14
resequestration.

Fourth, the complete absence of Cdc14 endocycles at zero Clb-Cdk

activity and the appearance of endocycles at ~1X peak Clb2kd (Fig. 4.11; 4.1),
suggests that the Cdc14-release-control module undergoes a ‘Hopf’ bifurcation to
give rise to limit cycle behaviors at a specific Clb2-Cdk level less than the peak.
Direct measurement of the critical Clb2-Cdk level is difficult currently since Cdc14
release oscillation is coupled with cell cycle progression and endogenous Clb2
expression at sub-peak Clb2kd levels. However, ‘Hopf’ bifurcation is known to
have a generic (independent of functional forms or parameters) property that the
oscillation amplitude scales as ~ (Clb 2kd − Clb 2kd Critical ) around the bifurcation point.
In my experiments, Cdc14 endocycle always oscillates with full amplitude around 1X
peak Clb2kd (Fig. 4.1; 4.4), suggesting that the critical Clb2kd level at bifurcation
point should be significantly lower that 1x peak, which supports the idea that the
Cdc14 control system also operates at an oscillatory zone in wild type cells.

To explore this question further, I study if the intact Cdc14-release module can
still generate Cdc14 release cycles of a cell-cycle period under low Clb2 conditions
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(comparable to average Clb2 in a cell cycle). With <1X peak Clb2kd, I used LAT-B
to inhibit cytokinesis, budding and anaphase to study the autonomous behavior of this
module.

I also deleted BUB2 to avoid the interference of SPOC.

In the absence of

cell cycle progression by LAT-B, Cdc14 release cycles of a 90-minute period emerged
at 0.2X peak Clb2kd-GFP (Fig. 4.16D).

With <1X peak Clb2kd, 39/46 cells

exhibited Cdc14 endocycles, and the frequency-Clb2kd relationship followed a
similar rule as in Fig. 4.10B (Fig. 4.16E).

This result suggests that when promoting

normal Cdc14 release, this module still exhibits self-oscillatory behavior, though
entrained to cell cycle progression. Overall, those experiments suggest that this
module and its oscillatory behavior may control normal Cdc14 release in unperturbed
cell cycles, and the coupling of this module with cyclin-Cdk oscillator is required for
maintaining once-per-cell-cycle Cdc14 release in mitosis.

Control of Cdc14 release by an autonomous oscillator must be compatible with
the well-established restriction of Cdc14 release to late mitosis, at the end of the
cyclin-Cdk cycle. In the following sections, I propose that the Cdc14 oscillator is
entrained by the cyclin-Cdk oscillator, and extend this concept to other likely
oscillatory modules controlling different cell cycle events.
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7. Cyclin-Cdk oscillations could order cell cycle events
through phase-locking

Besides the Cdc14 endocycle, other key cell cycle events can occur
‘endocyclically’ in the absence of mitotic cyclin-Cdk oscillation or overall cell cycle
progression (see Introduction), and thus have the capacity to be driven by intrinsic
oscillating modules.

These observations are difficult to fit into the Cdk-ratchet

model, since two essential components of the ratchet model, Cdk activity oscillation
as the sole driver for cell cycle periodicity, and specific distinct Cdk thresholds for
multiple steps in each process, are irrelevant in such situations.

Therefore, I

considered other ways that cyclin-Cdk oscillations could still order cell cycle events,
independent of ratchet-like mechanisms.

My observation that the frequency of Cdc14 release endocycle was controlled by
Clb2kd concentration (Fig. 4.10B) within a physiological range suggests that
cyclin-Cdk oscillations could entrain other autonomous oscillatory modules to form
an orderly and coherent cell cycle progression (Fig. 4.19A). Such entrainment, or
‘phase-locking’, is a known phenomenon in which oscillators with difference intrinsic
frequencies can synchronize, if the frequency of one is controlled by the activity of
the other (Glass, 2001; Winfree, 1967).

When phase-locked, their stable phase offset

is determined by their intrinsic frequency difference and simple properties of their

149

interactions (Winfree, 1967).
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Figure 4.19

Figure 4.19. Cell cycle control through phase-locking.

A. Schematic of ratchet

(above) and phase-locking (below). B. Conceptual model: three Kuramoto
oscillators ((Kuramoto, 1975), Materials and Methods) with different frequencies
(indicated) control different cell cycle events. Without entrainment there is no fixed
order (left) among events they generate. Allowing a cyclin-Cdk oscillator to advance
or delay part of the peripheral oscillators’ cycles leads to phase-locking and a stable
order of events (Right).
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To demonstrate how phase-locking could order cell cycle events controlled by
independent modular oscillators, I built a conceptual model containing four oscillating
modules.

One is the cyclin-Cdk oscillator, and the other three are autonomous

‘peripheral’ oscillators controlling specific cell cycle events (in this example, loosely
modeled after budding, SPB duplication, [see Introduction] and Cdc14 release).
Without any coupling, the different intrinsic frequencies of the peripheral oscillators
results in a disordered and irregular relative sequence of cell cycle events (Fig. 4.19B,
left).

Computer simulations showed that allowing the cyclin-Cdk master oscillator

to affect the frequencies of the peripheral oscillators resulted in the three peripheral
modules oscillating at a common frequency, producing events occurring once per
cyclin-Cdk cycle in a fixed order (Fig. 4.19B, right).

The model in Fig. 4.19B is only a cartoon representation of a possible cell cycle
control mechanism. However, the qualitative result of a distinct, dynamically stable
phase-locking solution for each oscillating module, given sufficient interactions with
the Cdk oscillator, may be robust to true biological complexity, since the stability of
the phase-locking solution is only determined by the local dynamical structure near
the fixed point (Winfree, 1967), meaning that phase-locking can occur largely
independent of detailed mechanism.

The only requirements are sufficiently strong

linkage, combined with reasonably close intrinsic frequencies; both of these features
are likely highly evolvable given initially independent oscillators (see Discussion).
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8. Reducing amplitude of the cyclin-Cdk oscillator results in
disordered cell cycle events

Phase-locking models of the general sort shown in Fig. 4.19B lead to a key
prediction: lowering the amplitude of Clb-Cdk oscillation should simultaneously
weaken entrainment between the Clb cycle and other Clb-controlled events,
potentially perturbing the order of cell-cycle events (Fig. 4.20A).

Thus, if other cell

cycle events are under control of other independent oscillators, then reducing the
amplitude of Clb-Cdk oscillations could result in scrambling of the order of these
events.

Importantly, this prediction is largely independent of the detailed structure or
parameters of the phase-locking model. An entirely different prediction is made
based on ratchet-type control (again, largely independent of detailed mechanism):
lowering amplitude should either block events or delay some steps, but not put events
out of order.
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Figure 4.20. Experimental test of phase-locking predictions. A. Model as in Fig.
4.19B, but the amplitude of cyclin-Cdk oscillation is reduced by 15%, resulting in
event disorder (compare Fig. 4.19B, right).

B. 2XGAL1-SIC1 bub2Δ or cdh1Δ sic1Δ

bub2Δ strains may reduce the amplitude of cyclin-Cdk oscillation by lowering the
peak Cdk activity or raising the trough (cartoon below). 2XGAL1-SIC1 cells (n=37)
were grown in raffinose medium prior to time-lapse analysis on galactose medium to
induce Sic1 (t=0). cdh1Δ sic1Δ GALL-CDC20 cells (n=35) were imaged on glucose
to turn off GALL-CDC20.

Quantification of the phenotype of the first cell cycle

(right) and representative traces.
budding; red bars: cytokinesis.

Blue bars: nucleolar separation; Green bars:
C. Cdc14 release and SPB duplication timing in

free-running cell cycles predicted by a quantitative phase-locking model. Red: best
estimation of parameters; blue: sine wave simulation of Clb-Cdk cycle. Light-red:
solutions with parameters altered +/- one standard deviation for one or both of the two
parameters (for two combinations no solution could be obtained due to mathematical
restrictions of the model; Materials and Methods). Right panel: phase-locking could
entrain SPB duplication oscillator (red) to the correct position early in the Clb-Cdk
cycle (blue) (Materials and Methods).

154

Figure 4.20
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I tried two strategies to test this prediction, that lowering the amplitude of
cyclin-Cdk oscillation should perturb the order of cell cycle events.

I first used

strong constitutive overexpression of the Sic1 inhibitor of Clb-Cdk activity from the
GAL1 promoter (Mendenhall and Hodge, 1998).

Wild-type cells already have a very

low trough (G1) level of Clb-Cdk activity due to high endogenous Sic1 accumulation
and other mechanisms (Mendenhall and Hodge, 1998) ; Sic1 overexpression therefore
seems unlikely to lower the trough level further, but could lower the peak level by
constitutive inhibitor production, thus reducing the amplitude (Fig. 4.20B).
2XGAL1-SIC1 cells are fully viable on galactose medium, so this perturbation is, on
the surface, not an extreme one.

As a nearly opposite means to lower the amplitude,

I used deletion of CDH1 and SIC1, which results in a high trough level of Clb2-Cdk
activity, probably not much lower than the peak level (Schwab et al., 1997; Visintin et
al., 1997) (Fig. 4.20B).

Although cdh1Δ sic1Δ cells are ultimately inviable (Schwab

et al., 1997; Visintin et al., 1997), they undergo multiple cell cycles (Wäsch and Cross,
2002), allowing analysis of order of events by time-lapse microscopy.

Note that

these two mechanisms for reducing the amplitude may do so in one case by lowering
the peak, and in the other case by raising the trough.

A ratchet control model, in

which specific Clb-Cdk levels are controlling sequential steps in a process, should
predict very different results from these manipulations, since Clb-Cdk activity levels
will be very different; for example, in GAL-SIC1 cells, Clb-Cdk levels are extremely
low during an extended G1, while in cdh1Δ sic1Δ cells there is probably no period
with low Clb-Cdk levels (Wäsch and Cross, 2002).
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In contrast, the phase-locking

perspective can predict qualitatively similar outcomes of event disorder, and even
obtaining identical outcomes is theoretically possible, depending on the nature and
strength of coupling.

In these experiments, in order to focus specifically on reduction of amplitude of
the Clb-Cdk oscillation, I also knocked out the spindle orientation checkpoint
component BUB2, which should relieve dependence of Cdc14 release on spindle
positioning (Bardin et al., 2000).

(This genetic manipulation was indeed necessary

for the full effects described below, although qualitatively similar effects on budding,
cytokinesis, and anaphase were observed in a BUB2 background; bub2 deletion alone
had no effect [data not shown]).

GAL1-SIC1 expression in bub2Δ cells resulted in 64% abnormal first cell cycles
after Sic1 expression on galactose medium (supernumerary Cdc14 release without
nucleolar separation; extra budding without Cdc14 release or cell division; or
cytokinesis without Cdc14 release or nucleolar separation (Fig. 4.20B), resulting in a
supernumerary bud following cytokinesis, which then fails to grow, presumably due
to being anucleate).

Remarkably, similar cell cycle anomalies with roughly similar

frequencies were also observed in cycling cdh1Δ sic1Δ bub2Δ cells.

The conceptual phase-locking model qualitatively reproduced the loss-of-order
phenotypes resulting from lowering the amplitude of Cdk oscillation (Fig. 4.20A).
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Those anomalies are not likely due to nonspecific growth defects since GAL1-SIC1
bub2 cells grow well both in bulk culture and when monitored as single cells. cdh1Δ
sic1Δ occasionally causes permanent cell cycle block with large budded cells; such
cells were excluded from analysis. In contrast, any Cdk-ratchet model would predict
that reducing the Cdk oscillation amplitude will lead to elongation of cell cycle period
or complete block of cell cycle progression; in either case, the normal orders of cell
cycle events would be predicted to remain the same.

Further, near-opposite

phenotypes would be predicted for lowering the peak vs. raising the trough.
Therefore, these results support phase-locking over ratchet control.

The phase-locking model describes how Cdk oscillation entrains autonomous
peripheral oscillators to form a coherent cell cycle.

This model coherently associates

the cycling of an event (e.g. Cdc14 release, SPB duplication) in normal cell cycles
with its capacity to operate in endocycles in blocked cells.

The phase-locking model

implies that these two phenotypes are driven by the same inherently oscillatory
module, which is entrained to the cyclin-Cdk oscillation in normally cycling cells.
In contrast, these two phenotypes are essentially uncoupled and independent of each
other in any ratchet model that somehow incorporates the possibility of endocycles as
a (pathological) consequence of cell cycle blockage.

Therefore, an empirical test of

the phase-locking vs. the ratchet perspective is to ask whether the response of the
oscillatory module to fixed Clb-Cdk levels is predictive of timing in the normal cell
cycle.

To carry out this test, I derived an equation to calculate the stable phase offset
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(the difference between peak Clb2 and peak Cdc14 release), based on the
phase-locking model.

This model contained only three parameters, all of which

were extracted directly from the empirical observations (importantly, derived solely
from Clb2kd-blocked cells) in Fig. 4.10B (Materials and Methods). A key parameter
is the strength of coupling of Clb2 to the frequency of the Cdc14 cycles (as noted
above, such coupling is indispensable for a phase-locking mechanism); this is simply
determined as the slope of the straight-line fit in Fig. 4.10B.
analytically to determine the phase-offset.

I solved the model

This calculation placed Cdc14 release

late in the cell cycle, as Clb-Cdk levels decreased, consistent with experiment
(Stegmeier and Amon, 2004).

This conclusion is not especially sensitive to

uncertainties in estimating the parameters, since a similar result is obtained increasing
or decreasing the parameter estimates by one standard deviation of measurement error,
alone or in combination (Fig. 4.20C).

A ratchet model can accommodate the

observations of Cdc14 endocycles in Clb2kd cells only by asserting that these
endocycles are due to pathological conditions of Clb2kd accumulation; in this case,
parameters derived from experiments with Clb2kd-blocked cells will be irrelevant to
timing in cycling cells.

The phase-locking model can be applied to any oscillating module under the
control of Cdk activity. I performed the same test on the hypothesized SPB
duplication module to see if this model can ‘predict’ the timing of SPB duplication in
normal cell cycles.

Published data are insufficient to obtain empirical estimates of
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parameters to calculate the timing of SPB duplications.

Still, I could estimate

predicted timing using my model and plausible parameter choices (Materials and
Methods). SPB duplication was predicted to occur early in the cell cycle, before the
rise in Clb-Cdk, as observed experimentally (Fig. 4.20C).

This result shows

consistency of timing of SPB duplication with a phase-locking model.

The severe disruptions in normal Cdc14 release by manipulations specifically
predicted to perturb the autonomous Cdc14 release module, even in free-running cell
cycles, imply that oscillatory function of this module and its coupling to Clb-Cdk
oscillations is required for normal Cdc14 release timing.

It is likely that any

phase-locking control system could transit evolutionarily to a pure ratchet-control
system; indeed, this is formally the result of increasing coupling strength to arbitrarily
high values, such that the peripheral oscillator will not move within a physiological
timescale without a ‘kick’ from the entraining oscillator.

Different cell cycle systems,

even if initially independently oscillatory, may vary in the degree to which they are at
present under ratchet control; for example, DNA replication may be entirely under
cyclin-Cdk ratchet control in modern eukaryotes, despite its intrinsically oscillatory
character. This may represent a tradeoff between the robustness and simplicity of
the PL mechanism, and the cost in some systems of occasional uncoupling
(aneuploidy in the case of DNA replication).
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9. Implications for the evolution of the cell cycle

Modularity in biology has been argued to create functional robustness and
evolvability (Bhattacharyya et al., 2006; Hartwell et al., 1999).

My study suggests

that certain modules in cell cycle are intrinsically oscillatory; coupling of these
oscillators to the central Cdk oscillator can nevertheless readily ensure
once-per-cell-cycle events (Fig. 4.19A).

The eukaryotic cell cycle evolved from Cdk-free precursor(s), since Cdk is a
eukaryotic-specific kinase (Nasmyth, 1995). Critical biological processes such as
DNA replication and cell division obviously predated Cdk, and may be intrinsically
cyclical processes ultimately brought under control of a Cdk oscillator by
phase-locking.

Consistent with this idea, Cdks may have evolved late, after other

eukaryotic cell-cycle-regulatory protein kinases (Krylov et al., 2003).

If cell cycle

processes were intrinsically oscillatory before the emergence of Cdk, then Cdk would
only need to gain the ability to modulate these oscillators to gradually become a
master regulator.

This provides a clear evolutionary case with plausible selection for

utility of intermediate forms (Darwin, 1859). In contrast, direct evolution of ratchet
control appears to require much more ‘forceful’ evolutionary change.

I speculate that in primordial eukaryotes, multiple autonomous biochemical
oscillators entrained each other to an approximate aggregate rhythm.
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Cyclin-Cdk

oscillation could then have emerged as a central cell cycle controller to stabilize the
phase-locking structure. In computer simulations, selection for entrainment in large
oscillator populations efficiently yielded central pacemaker oscillators (Brede, 2008;
Sendina-Nadal et al., 2008). These evolved pacemaker systems exhibited high
stability to weakening of oscillator coupling as an unselected ‘phenotype’ (Brede,
2008).

To understand the advantage of having a central oscillatory controller like

Cdk, I constructed random networks of coupled Kuramoto oscillators (Kuramoto,
1975) in computer simulation.

Increasing centralization of control by gradually

changing network connections increased the stability of spontaneous entrainment (Fig.
4.21).

This result could potentially justify the evolution of cyclin-Cdk oscillator

system.
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Figure 4.21. Simulation showing that centralization of control enhances global
entrainment in an oscillator network. For a range of coupling strengths
(equivalent to magnitude of the Z response curve; see Materials and Methods) on the
x-axis, we randomly generated Kuramoto oscillator networks containing 100
independent oscillators, either connected randomly (black), or with preference for
in-connection from an oscillator that already has multiple out-connections
(preferential exponent=1.0 in green, or 2.0 in blue, see Materials and Methods). For
all networks, the average number of ‘in’ and ‘out’ connections was constrained to be
the same (<k>=2). Inset: the out-degree distribution (kout) for each connection
scheme: increasing preferential connection resulted in networks with a small number
of highly out-connected nodes (cluster of low frequency green and blue points with
high kout). The networks were run from random initial conditions and random
intrinsic frequencies for each of the 100 nodes. An order parameter R was calculated

∑ e ϕ dt ( ϕ i is
N ⋅T ∫

for each network to determine the degree of entrainment R = 1

T

0

N

i

i

i =0

the phase of the ith oscillator; T=100, N=100; R=1 represents complete entrainments,
see Materials and Methods). 1000 networks were sampled randomly for each coupling
strength. Shaded areas: standard deviations. At all coupling strengths, increasing
centralization of oscillator coupling enhanced entrainment (blue curve > green curve
> black curve)
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Figure 4.21
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10. Mob1-GFP localizes to SPB in phase with Cdc14 release
during Cdc14 endocycles.

Mob1 is an essential component of the mitotic exit network (MEN) (Stegmeier
and Amon, 2004).

Mob1-GFP localizes to both daughter- and mother-orientated

SPB during ME, coinciding with Cdc14 release (Yoshida and Toh-e, 2001). It has
been suggested that Mob1’s SPB localization is important for its activation, although
a direct causal relationship has not been shown (Stegmeier and Amon, 2004).

Cdc14 can dephosphorylate Cdc15, another essential MEN component upstream
of Mob1, probably leading to full activation of the MEN (Jaspersen and Morgan,
2000; Stegmeier et al., 2002).

In order to study whether MEN activity also oscillates

during the Cdc14 endocycles, I examined the localization of Mob1-GFP in the Clb2kd
pulse experiment.

In 9/10 cells showing Cdc14 endocycles, Mob1-GFP localization

also changed periodically, and its SPB localization coincided with Cdc14 release (Fig.
4.22). This observation suggests that the MEN activity may also oscillate during the
Cdc14 endocycles, although I lack a technical means to directly measure Dbf2 kinase
activity, the likely final effector of the MEN pathway, in single-cell analysis.
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Figure 4.22

Figure 4.22. Mob1-GFP localization during the Cdc14 endocycles.
MET-CDC20 MOB1-GFP CDC14-YFP NET1-mCherry cells were pulsed with
Clb2kd for 30 minutes as in Fig. 4.1D, and released into cell cycle.

The maximum

GFP intensity was used a proxy for Mob1-GFP SPB localization (higher value
indicates stronger SPB localization). In 9/10 cell showing Cdc14 endocycles,
Mcm2-GFP SPB localization appeared to oscillate in-phase with Cdc14 release.
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11. Bypassing the lethality of cdc14Δ and the role of Cdc14
phosphatase activity in its resequestration

Cdc14 is normally essential for cell viability. It has been shown that shortening
the length of rDNA allows GAL1-SIC1 overexpression to rescue the cdc14-1
temperature sensitive allele at restrictive temperatures (Machin et al., 2006).

I

created a cdc14Δ strain with shortened rDNA and GAL1-SIC1 overexpression. This
strain was viable and slow-growing on galactose medium, but totally inviable on
glucose medium (without Sic1 overexpression).

The existence of this strain strongly suggests that the cyclin-Cdk cycle is
intrinsically more important and primary in cell cycle regulation than the Cdc14 cycle;
this idea is consistent with the universal conserved role of cyclin-Cdk in regulating
the eukaryotic cell cycle, as compared to the more variable and less central role of
Cdc14 in other eukaryotes (Morgan, 2007).

A similar strain construction

demonstrated that the anaphase-promoting complex is dispensable provided that
periodic cyclin-Cdk regulation is allowed (Thornton and Toczyski, 2003).

These

results suggest that cyclin-Cdk is truly the ultimate driver of cell cycle regulation.
In addition, the cdc14Δ strain can be employed to study an important question:
whether Cdc14 resequestration into nucleolus requires Cdc14 phosphatase activity.
Cdc14 has been proposed to promote its return to the nucleolus after release by
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dephosphorylating several targets including Bub2, Lte1, Cdh1, and Net1 (Stegmeier
and Amon, 2004).

However, inactivating Cdc14 phosphatase activity usually leads

to mitotic cyclin stabilization and ME block.

Mitotic cyclin-Cdk activity also

controls Cdc14 localization, which complicates the explanation of results as to
whether the Cdc14 requirement for its nucleolar resequestration it is due to lack of
Cdc14 phosphatase activity per se or due to high mitotic cyclin-Cdk activity. (These
activities are further intertwined by the likely direct dephosphorylation of multiple
cyclin-Cdk targets by Cdc14).

I employed the cdc14Δ strain to address this problem.

I introduced a

phosphatase-inactive cdc14C283S/R289A-GFP construct into the cdc14Δ background
(with shortened rDNA and GAL-SIC1 expression).

The catalytically inactive

cdc14C283S/R289A-GFP had essentially no effect on the strain’s phenotype, which
included massive cytokinetic defects and frequent cell cycle arrest.

I used time-lapse

microscope to specifically examine cycling cells, to observe localization changes of
catalytically inactive Cdc14. Within this population, 17/21 cells under investigation
demonstrated a clear release/resequestration pattern comparable to that of wild type
cells (Fig. 4.23).

Occasionally, Cdc14 release lasted longer than the 20 minutes

characteristic of wild-type.

The amplitude of Cdc14 release appeared to be smaller

than wild type, but due to the elongated cell morphology in cdc14C283S/R289A-GFP
GAL1-SIC1 cells, direct quantitative comparison with wild type cells is difficult.
Therefore, I conclude that Cdc14 phosphatase activity may contribute to, but is not
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strongly required for Cdc14 resequestration. In the absence of Cdc14 phosphatase
activity, other phosphatases may also dephosphorylate relevant targets after mitotic
cyclin inactivation to promote Cdc14 resequestration, especially with strong
overexpression of the Sic1 cyclin-Cdk inhibitor.
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Figure 4.23

Figure 4.23. The phosphatase activity of Cdc14 is not absolutely required for its
nuclear sequestration.

cdc14::cdc14C283S/R289A-GFP NET1-mcherry

GAL1-SIC1 short-rDNA was grown in galactose medium and analyzed using
time-lapse microscopy.

Due to massive growth defects, only cycling cells were

picked up. 3 cell lineages show that Cdc14 nucleolar localization is still cell cycle
regulated in dividing cells (n=15). Traces are shifted along Y-axis for presentation.
Blue bars: anaphase; green bars: budding.
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12. Discussion
Here, I propose that an intrinsic oscillatory module controls Cdc14 release, and
that cyclin-Cdk oscillation could order Cdc14 release, and likely other cell cycle
events under independent oscillator control, by phase-locking these modules to the
frequency of the cyclin-Cdk cycle.

I describe the capacity of Cdc14 release and resequestration to oscillate
spontaneously, independent of Clb-Cdk oscillations and thus independent of the main
cell cycle driver.

This oscillatory module functioned at varying fixed Clb2-Cdk

levels; importantly, though, Clb-Cdk levels nevertheless regulated the Cdc14
oscillator, with higher Clb-Cdk increasing Cdc14 release frequency.

The canonical model for once-per-cell-cycle regulation by cyclin-Cdk oscillations
proposes that high and low cyclin-Cdk levels promote alternating steps of a process; I
refer to this as a ‘ratchet’ model (see Introduction).

Such a model rather clearly

predicts that any given fixed level of cyclin-Cdk should result in a terminal arrest with
one or the other steps of each cell cycle process completed and the next never
occurring. Cdc14 endocycles at fixed Clb2 levels are hard to reconcile with this idea;
further, there are at least three other once-per-cell-cycle events that are now known to
have the potential to occur in a cyclical fashion independent of cyclin-Cdk oscillations:
budding, cell-cycle-regulated transcription, and SPB duplication.

As an alternative

to ratchet models, to account for existence and entrainment of these endocycles at a
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common frequency, I propose here a phase-locking model by Cdk oscillation to order
cell cycle events.

It is important to note that such a phase-locking model is consistent with
mechanistic regulatory details that are frequently interpreted as support for ratchet
models; for example, the documented ability of high mitotic cyclin-Cdk activity to
prevent SPB ‘licensing’ for duplication is not somehow ‘eliminated’ by a
phase-locking model – it is considered as a mechanism of oscillator coupling. The
phase-locking model may provide deeper insight into cell cycle regulation since it
incorporates the endocycle phenotypes, which despite the accumulation of an
increasing number of examples, must be regarded as ‘outliers’ or artifacts in order to
maintain the generality of ratchet-type models. I generated and tested qualitative
predictions of phase-locking models that clearly differ from the predictions of ratchet
models, and the phase-locking model appeared to give a better fit.

Further, I generated a simple but quantitative phase-locking model with
parameters estimated solely from experiments on cells blocked in the cell cycle by
undegradable mitotic cyclin.

This model then predicted Cdc14 release from the

nucleolus late in the cell cycle, as the Clb-Cdk level is declining, as is observed
experimentally.

This result is empirically meaningful since estimates from blocked

cells, placed in the phase-locking model, yielded a correct answer for freely cycling
cells, suggesting that the normal Cdc14 release cycles and endocycles are closely
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related phenotypes, likely driven by the same oscillatory module.

The predominant model for cell cycle control involves direct cyclin-Cdk control
of cell cycle events, with surveillance checkpoints to ensure order. An earlier model,
derived from the study of cdc mutants (Morgan, 2007), considered cell cycle control
to be due to parallel, interlocking but unidirectional morphogenetic pathways
arranged in a functional sequence map. My phase-locking model combines aspects
of both models: a central cyclin-Cdk oscillator drives the cell cycle as in the first
model; functional sequences emerge in the phase-locking model as independent
oscillatory modules controlling specific cell cycle events. Such independent cyclical
processes are highly analogous to ‘independent functional sequences’ in the original
cdc formulation – processes that can operate freely in parallel, such as DNA
replication and spindle morphogenesis (Hartwell, 1974).

Such an arrangement gives

great flexibility and resistance to deleterious effects of delays, once surveillance
‘checkpoint’ mechanisms are in place. Phase-locking of these autonomous
oscillators by a central Cdk pacemaker could have been an important early event in
cell cycle evolution, and this mechanism may control multiple autonomous cell cycle
oscillators, even in modern eukaryotes.
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13. Unsolved issues

1. What is the nature of the small amplitude oscillation of Cdc14 release in cdh1Δ
cells with >2x peak Clb2kd?

I did not observe this small amplitude oscillation in

the presence of CHX, indicating that transcriptional regulation may also drive this
phenotype. I have shown that Cdc14 release induced by Esp1 overexpression is
more nuclear-concentrated in cdh1Δ cells than CDH1+ (Fig. 3.15).

Therefore,

the reduced amplitude may reflect the fact that Cdc14 can still concentrates in the
nucleus after nucleolar release; assuming microscopic colocalization of some of
the nuclear-concentrated Cdc14 with nucleolar Net1 (a reasonable assumption
given imperfect geometry and the close contact between nucleus and nucleolus),
the quantitative measure of Cdc14 release would necessarily adopt a lower
amplitude even if fully released from the nucleolus.

High levels of mitotic

cyclin-Cdk may block Cdc14 nuclear export (Fig. 3.15), which is also consistent
with this observation.

2. Does oscillation of MEN activity drive the Cdc14 endocycle in cdh1 sic1 bub2
cells? and what is role of MEN in promoting Cdc14 endocycles in Clb2kd cells, if
any?

Using Mob1-GFP construct to observe its SPB localization may answer

this question.
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3. What is the threshold of Cdc5 for Cdc14 release?
amplitude is not controlled by Clb2kd levels.

I observed that Cdc14 release

The digital behavior of Cdc14

release can be explained by either positive feedbacks in Cdc14 control network or
a sharp threshold for the Cdc5 level. To determine the Cdc5 threshold, cells
should be blocked in telophase by depleting Cdc5 using cdc5::MET3-CDC5.
Then various concentrations of stable Cdc5-ΔNT-GFP could be expressed in the
cell to correlate Cdc14 localization changes with Cdc5 level, as I did for
Clb2kd-GFP.

4.

If Cdc14 release controlled by Cdk oscillation through phase-locking, why is
DNA replication much more likely controlled through a ratchet mechanism?
Besides the possibility that those two events followed different evolutionary
routes, it is possible that phase-locking and ratchet mechanisms may have
specific advantages that make them suitable for different circumstances. Cdc14
endocycles may be utilized by the cells under certain physiological conditions.
The likely ability of Cdc14 to inactivate the spindle checkpoint (see above)
combined with potential Cdc14 oscillations under some conditions marginally
activating the checkpoint, could periodically provide an escape ‘opportunity’ for
checkpoint-arrested cells, i.e., a recovery mechanism.

In this context, it is

interesting that adaptation to some forms of checkpoint arrest has been linked to
Cdc5 (Toczyski et al., 1997), which is essential for Cdc14 release, including in
endocycles (see above). Periodic chromosome decondensation/recondensation
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in animal cells blocked in mitosis with colcemid is a classical observation that
comes to mind.

Formally similar proposals have been made to rationalize the

physiological significance of the Mdm2-p53 oscillation in mammalian cells after
DNA damage, where the oscillatory phenotype could be important for DNA
damage repair.

5. Can the cell cycle be driven by oscillation of phosphates activity alone?

Free

control of Cdc14 localization or activity may be important for answering this
question. Besides deleting NET1, constitutive Cdc14 release throughout the cell
cycle has not been achieved (and net1 deletion in fact does not result in full
release of Cdc14, as I showed in Chapter 3, since Cdc14 is largely
nuclear-restricted in the absence of Net1).

Using GAL/MET-URL-CDC14-YFP

construct, and periodically controlling promoter activities with a microfluidic
system could be feasible, to see if normal cell cycle progression can be achieved
in the presence of constitutive mitotic cyclin-Cdk activity (CLB2kd sic1Δ).
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Epilogue

Theory and complexity

One familiar with images of fractals may be amazed by the great details of their
fine structures. However, a fractal image is usually generated by a rather short
computer program, typically less than 100 letters. Does the short program contain
the same amount of information as the fractal images it generates?

What if the

generation involves uncertainty or noise?

The organic world contains unlimited possibility and complexity, which
traditional methodology, namely reductionism, appears rather inefficient in dealing
with.

There must be at least two reasons: 1. Complexity is an inherent property of

any biological system that emerges from myriads of ‘frozen incidences’ during billon
years of evolution.

Meanwhile, its evolvability depends on the ability to generate

enough phenotypic variations.

2. Partially due to the first reason, biologists are

usually satisfied with qualitative results on their questions, which creates ambiguity
and even leads to wrong conclusions. Just like looking at ultra-low resolution
images.

The same object could appear quite differently, and different objects could

appear the same.

The contribution of theories to understanding biology is subtle, most successfully
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in summarizing experimental results. Better ones could reflect dynamic modes
common in different systems.

To me, a good theory should provide a novel way of

reasoning, even about old things. Information theory and game theory, for example,
do not solve previously forbidden questions, but provide a natural and concise way to
re-analyze them, thus increase the efficiency of human brains at working on questions
which they are not evolved to be good at. Therefore, ‘concepts’ may be what we
really need.

We can not consider that there is a simple common principle underlying each
phenomenon within different systems, more than a wish.

Due to the complexity of

its nature, it’s often necessary to neglect some facts when trying to summary a
theoretical model.

The mind primed by any particular model or paradigm tends to

discriminate among experimental approaches and results, intentionally or
unintentionally, merely for the simplicity and beauty of its proof. ‘It’s a tragedy
when a beautiful theory in physics is disproved by ugly experiments.’ In biology, it
only means the theory is not beautiful enough.

To understand or apply any theoretical model, it is very important to distinguish
between what should happen and what actually happened. Models of any kinds are
merely ways to describe and justify observations, for our own convenience. This
straightforward notion tends to be ignored by many, mostly because, I think, blurring
the distinction between theory and reality is important for cultivating intuitions,
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although sometimes, quite misleading.

Efficiency and curiosity

When you lose something, do you immediately search all possible places, or take
some time first to think carefully where it could be?

Conducting biological research

sometimes is like looking for lost things, except that what you find may not be what
you expected.

Biologists are accumulating information at an amazing speed. Eventually, any
particular question will be answered, slowly but surely (physicists are less lucky in
this aspect). The real question is how to get there most efficiently.

After the goal is

enlightened by curiosity, collecting all available information and analyzing it is the
first step. That allows distinguishing promising way(s) to go.

It is also important

to wander around occasionally to avoid or escape traps on the path.

A similar idea is

called ‘simulated annealing’, and has been quite useful to me.

The progression of science seldom follows people’s expectation. Intellectual
works of great brains shine only as time goes by.

Certain attempts that will almost

for sure not fall into that category, such as conducting biological experiments catering
a well-established model to establish faked satisfaction to the lay, in that neither new
information nor fresh ways of analysis is provided, shall be avoided in any cases.
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